# Chapter 124: Major or Mild Frontotemporal Neurocognitive Disorder

## The Biological and Neurological Basis of Major or Mild Frontotemporal Neurocognitive Disorder

### Introduction

Major or Mild Frontotemporal Neurocognitive Disorder (FTNCD) represents a group of clinically and pathologically heterogeneous neurodegenerative diseases that primarily compromise the structural and functional integrity of the frontal and temporal lobes of the brain (Kerchner & Rosenbloom, 2014; Schlachetzki, 2011). Historically overshadowed by Alzheimer's disease (AD), FTNCD is now recognized as a common cause of dementia, particularly in individuals under the age of 65 (Kerchner & Rosenbloom, 2014; Kuğu et al., 2010). Unlike AD, where memory impairment is the cardinal early feature, FTNCD typically presents with an insidious onset of profound changes in personality, social conduct, and language abilities, while memory and visuospatial functions may remain relatively preserved in the initial stages (Kerchner & Rosenbloom, 2014; Schlachetzki, 2011; Honig et al., 2003).

The disorder is broadly categorized into two principal clinical syndromes: the behavioral-variant (bvFTNCD) and the language-variant (Lv-FTNCD), also known as primary progressive aphasia (PPA) (Kerchner & Rosenbloom, 2014; Boeve, 2004). BvFTNCD is characterized by a progressive decline in social cognition and executive abilities, manifesting as behavioral disinhibition, apathy, loss of empathy, and compulsive behaviors (Kerchner & Rosenbloom, 2014; Mendez et al., 2008). Lv-FTNCD is further subdivided into progressive nonfluent aphasia (PNFA), marked by agrammatism and effortful speech, and semantic dementia (SD), characterized by a progressive loss of word comprehension and object knowledge (Kerchner & Rosenbloom, 2014; Mesulam, 2013; Boeve, 2004). In some cases, FTNCD can be accompanied by features of motor neuron disease (MND), presenting a devastating overlap syndrome (Kerchner & Rosenbloom, 2014; Mitsuyama, 1984; Mitsuyama, 2000).

From a biological perspective, FTNCD is not a single disease but an umbrella term for a spectrum of underlying pathologies collectively referred to as frontotemporal lobar degeneration (FTLD) (Kerchner & Rosenbloom, 2014; Mann, 2010). FTLD is distinct from the pathology of AD and is defined by the abnormal aggregation of specific proteins within neurons and glia of the affected brain regions (Kerchner & Rosenbloom, 2014; Honig et al., 2003). The three main pathological subtypes are characterized by inclusions of the proteins tau, transactive response DNA-binding protein 43 (TDP-43), and fused-in-sarcoma (FUS) (Kerchner & Rosenbloom, 2014). The clinical phenotype does not reliably predict the underlying molecular pathology, creating significant diagnostic challenges and underscoring the heterogeneity of the disorder (Kerchner & Rosenbloom, 2014; Miki et al., 2016).

This chapter will provide a comprehensive overview of the biological and neurological foundations of FTNCD. It will explore the implicated neurotransmitter systems and neuropharmacology, the specific brain regions and neural circuits that are disrupted, and the genetic and molecular mechanisms that drive the disease process. Furthermore, it will detail the cellular and synaptic mechanisms of neurodegeneration, review key findings from structural and functional neuroimaging, and discuss the disorder's biological subtypes and heterogeneity. By synthesizing evidence from the available literature, this chapter aims to construct a detailed picture of the neurobiological landscape of FTNCD, acknowledging its complexity and the ongoing quest to understand its fundamental mechanisms.

### Neurobiological Systems

The clinical manifestations of FTNCD, ranging from profound personality changes to severe language deficits, are direct consequences of the progressive dysfunction of specific neurobiological systems (Kerchner & Rosenbloom, 2014; Cummings, 1999). The selective vulnerability of the frontal and temporal lobes disrupts highly organized neural circuits that govern executive function, social cognition, emotional regulation, and language (Bonelli & Cummings, 2007; Espay, 2009). While the precise neurochemical alterations in FTNCD are not as well-defined as in other neurodegenerative conditions like Parkinson's disease, the symptom profile provides critical clues into the neurotransmitter systems that are likely implicated.

**Neurotransmitter Systems and Neuropharmacology**

The behavioral symptoms of bvFTNCD, such as apathy, disinhibition, impulsivity, and obsessive-compulsive behaviors, strongly suggest dysfunction in key monoaminergic systems, including the dopaminergic, serotonergic, and noradrenergic pathways (Moretti et al., 2005; Mendez et al., 2008). These systems are known to modulate mood, motivation, and impulse control (Cummings, 1999; Fiar et al., 2012).

The dopamine system, particularly projections to the prefrontal cortex and striatum, is critical for motivation, reward processing, and executive function (Bonelli & Cummings, 2007; Beninger, 2018). The profound apathy and inertia seen in many bvFTNCD patients, characterized by a loss of drive and initiative, may reflect a state of dopaminergic hypofunction within the medial frontal-subcortical circuits (Bonelli & Cummings, 2007; Moretti et al., 2005; Mucci et al., 2021). This parallels the negative symptoms of schizophrenia, such as avolition, which are also linked to hypofrontality and disturbances in dopamine transmission (Dodd, 2007; Kirkpatrick, 2014; Ereshefsky et al., 1990). Conversely, behaviors like impulsivity, disinhibition, and repetitive or stereotyped actions could be related to dysregulated or erratic dopaminergic signaling in orbitofrontal and striatal pathways (Bonelli & Cummings, 2007; Miki et al., 2016). The observation that stimulant drugs which increase dopamine release can cause psychotic symptoms (Dodd, 2007) and that antipsychotics which block D2 receptors can treat psychosis (Buckley & Foster, 2014) highlights the central role of dopamine in behavioral control. Some FTD patients have been noted to develop parkinsonism, suggesting involvement of the nigrostriatal dopamine system (Kerchner & Rosenbloom, 2014; Schlachetzki, 2011), which is the primary system affected in Parkinson's disease (Martínez‐Castrillo et al., 2011).

The serotonin (5-HT) system is deeply involved in regulating mood, anxiety, impulsivity, and social behavior (Liu et al., 2019; Moretti et al., 2005). The loss of empathy, emotional blunting, and socially inappropriate or disinhibited behaviors in bvFTNCD point to serotonergic dysregulation, particularly within the orbitofrontal and anterior cingulate cortices (Bonelli & Cummings, 2007; Moretti et al., 2005). Compulsive and ritualistic behaviors, which are a core feature of bvFTNCD (Kerchner & Rosenbloom, 2014), bear a striking resemblance to symptoms of obsessive-compulsive disorder (OCD), a condition in which serotonergic dysfunction is a key etiological factor (Murphy et al., 2010; Hartmann et al., 1993). Pharmacologically, selective serotonin reuptake inhibitors (SSRIs), which enhance serotonergic neurotransmission, have shown some efficacy in managing behavioral symptoms such as disinhibition in FTD (Moretti et al., 2005; Araújo et al., 2013), lending support to the involvement of this system.

The noradrenergic system, originating in the locus coeruleus, plays a major role in arousal, attention, and the response to stress (Liu et al., 2019; Musazzi & Marrocco, 2016). Apathy and attentional deficits in FTNCD could be related to noradrenergic hypofunction (Kerchner & Rosenbloom, 2014), while irritability and agitation might be linked to hyperactivity or dysregulation of this system (Bonelli & Cummings, 2007). In other conditions, such as depression and anxiety, both serotonin and norepinephrine are implicated (Fiar et al., 2012; Liu et al., 2019), and drugs that modulate both systems (SNRIs) are effective treatments (Hadi et al., 2017). This suggests a complex interplay between these monoamine systems in regulating affect and behavior, which is likely disrupted in FTNCD.

Finally, the cholinergic system, crucial for memory and attention, is the primary target of therapies for AD (Rucci & Feinstein, 2014). While prominent memory loss is not typically an early feature of FTNCD, attention deficits are a core part of the cognitive profile of bvFTNCD (Kerchner & Rosenbloom, 2014). Therefore, some degree of cholinergic dysfunction may contribute to the cognitive symptoms, although it is not considered the primary neurochemical deficit as it is in AD (Moretti et al., 2005; Arnaldi et al., 2012).

**Brain Regions, Neural Circuits, and Functional Connectivity**

The clinical syndromes of FTNCD are direct reflections of the topography of neurodegeneration within large-scale brain networks (Kerchner & Rosenbloom, 2014; Cummings, 1999). FTLD pathology preferentially targets the frontal and temporal lobes, disrupting critical circuits that underpin complex human behaviors (Bonelli & Cummings, 2007; Honig et al., 2003).

BvFTNCD is associated with atrophy that is often most pronounced in the right hemisphere, particularly involving the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and insula (Kerchner & Rosenbloom, 2014; Mahapatra et al., 2016). These regions are central hubs of the brain's social and emotional networks (Shany‐Ur & Rankin, 2011). The OFC is crucial for integrating emotional information into decision-making and for behavioral inhibition (Bonelli & Cummings, 2007; Mendez, 2022). Damage to the orbitofrontal-subcortical circuit leads to disinhibition, impulsivity, emotional lability, and impaired social judgment, which are hallmark features of bvFTNCD (Bonelli & Cummings, 2007; Mendez et al., 2008). The ACC is vital for motivated behavior, attention, and error monitoring (Bonelli & Cummings, 2007; Faustino, 2021). Dysfunction in the anterior cingulate circuit is thought to be the primary substrate for apathy, abulia, and inertia (Bonelli & Cummings, 2007; Mucci et al., 2021). The insula is implicated in interoception, emotional awareness, and empathy (Mahapatra et al., 2016; Mendez, 2022); its degeneration likely contributes to the profound loss of empathy and emotional blunting seen in bvFTNCD (Kerchner & Rosenbloom, 2014). Together, these regions form part of the salience network, which is involved in detecting and orienting attention to relevant internal and external stimuli (Kesby et al., 2021). Disruption of this network may underlie the aberrant social cognition and emotional processing in the disorder. The dorsolateral prefrontal cortex (DLPFC), a key node in the executive control network, is also frequently affected (Bonelli & Cummings, 2007). The dorsolateral prefrontal-subcortical circuit is responsible for executive functions such as planning, organization, working memory, and mental flexibility (Bonelli & Cummings, 2007; Cummings, 1995). Its impairment leads to the prominent decline in executive abilities seen in bvFTNCD (Kerchner & Rosenbloom, 2014).

The language variants of FTNCD, or PPA, result from focal atrophy within the left hemisphere language network (Mesulam, 2016; Narvid & Gorno‐Tempini, 2008). In progressive nonfluent aphasia (PNFA), atrophy is centered on the left frontoinsular and perisylvian regions (Kerchner & Rosenbloom, 2014), including Broca's area. This localization is consistent with the core symptoms of agrammatical speech and apraxia of speech, which reflect deficits in speech motor programming and syntax (Mesulam, 2013; Otsuki, 2015). In semantic dementia (SD), the neurodegeneration is focused on the anterior temporal lobes, often asymmetrically with greater involvement on the left (Kerchner & Rosenbloom, 2014; Boeve, 2004). This region is now understood to be a critical hub for semantic memory, including word comprehension and object knowledge (Mesulam, 2016; Vonk et al., 2019). Its atrophy leads to the characteristic anomia and impaired word comprehension of SD (Boeve, 2004; Gorno‐Tempini, 2008). The logopenic variant of PPA (lvPPA) is associated with atrophy in the left temporo-parietal junction area (Yoshino, 2011). This pattern of atrophy disrupts phonological working memory, leading to impaired sentence repetition and word-finding difficulties with prominent phonological errors (Yoshino, 2011; Maruta et al., 2016).

These frontal-subcortical circuits are not isolated; they are complex loops connecting specific cortical areas with the basal ganglia (striatum, globus pallidus, subthalamic nucleus) and thalamus (Bonelli & Cummings, 2007; Otsuki, 2012). Degeneration at any point in these circuits can produce the behavioral or cognitive syndrome associated with that loop (Cummings, 1995). The involvement of the basal ganglia may also explain the emergence of parkinsonism or other movement disorders in a subset of FTNCD patients (Kerchner & Rosenbloom, 2014; Esmonde et al., 1996).

### Genetic and Molecular Basis

Frontotemporal Neurocognitive Disorder is a clinically and pathologically diverse condition, and this heterogeneity is reflected in its complex genetic and molecular underpinnings (Kerchner & Rosenbloom, 2014; Mann, 2010). A significant proportion of FTNCD cases, estimated at around 40-50%, are familial, suggesting a strong genetic component (Honig et al., 2003; Szabó & Szabó, 2003). The identification of causative genetic mutations has been pivotal in understanding the molecular pathways that lead to frontotemporal lobar degeneration (FTLD) (Mann, 2010). Genetic testing and family history are now key components in diagnosing "probable" FTNCD (Kerchner & Rosenbloom, 2014; Falk & Moreno, 2019).

**Heritability and Major Genes**

The three most important genes associated with familial FTNCD are *MAPT* (microtubule-associated protein tau), *GRN* (progranulin), and *C9orf72* (Chromosome 9 open reading frame 72) (Mann, 2010). Mutations in these three genes account for a majority of autosomal dominant FTNCD cases.

Mutations in the *MAPT* gene, located on chromosome 17, were the first to be linked to FTLD (Mann, 2010). These mutations lead to the production of abnormal tau protein, which aggregates into neurofibrillary tangles and other inclusions within neurons and glia (Honig et al., 2003). This specific pathology is referred to as FTLD-tau (Kerchner & Rosenbloom, 2014). The clinical presentation of FTLD-tau is variable, but it is the most common pathology underlying the PNFA variant of FTNCD and is also frequently seen in bvFTNCD (Kerchner & Rosenbloom, 2014). Some patients with *MAPT* mutations present with parkinsonism, a syndrome termed frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) (Schlachetzki, 2011).

Mutations in the *GRN* gene, also on chromosome 17, typically cause disease through haploinsufficiency, meaning that one copy of the gene is inactivated, leading to a roughly 50% reduction in the production of the progranulin protein (Mann, 2010). The precise function of progranulin is still under investigation, but it is thought to be involved in neuronal survival, inflammation, and lysosomal function (Zhang, 2021). Reduced progranulin levels lead to the pathological aggregation of the TDP-43 protein, a pathology known as FTLD-TDP (Kerchner & Rosenbloom, 2014; Mann, 2010). FTLD-TDP is the most common underlying pathology for bvFTNCD and the SD variant of PPA (Kerchner & Rosenbloom, 2014).

The most common genetic cause of both FTNCD and amyotrophic lateral sclerosis (ALS, or motor neuron disease) is a hexanucleotide (GGGGCC) repeat expansion in a non-coding region of the *C9orf72* gene (Mann, 2010). This discovery explained the long-observed clinical overlap between FTD and MND (Mitsuyama, 1984; Mitsuyama, 2000). The pathogenic mechanisms of the *C9orf72* expansion are complex and thought to involve both a loss of function of the C9orf72 protein and a toxic gain of function from the repeat RNA and dipeptide repeat proteins translated from it (Mann, 2010). Like *GRN* mutations, the *C9orf72* expansion is associated with FTLD-TDP pathology (Kerchner & Rosenbloom, 2014).

Other, rarer genes have also been implicated in familial FTNCD, including *VCP*, *CHMP2B*, and *TARDBP* (the gene encoding TDP-43 itself) (Mann, 2010). This genetic heterogeneity underscores that multiple molecular pathways can converge on a final common pathway of frontotemporal neurodegeneration (Agid & Blin, 2007).

**Molecular Mechanisms and Pathological Subtypes**

The molecular classification of FTLD is based on the identity of the main protein that aggregates in neuronal and glial inclusions (Kerchner & Rosenbloom, 2014). The three major proteinopathies are FTLD-tau, FTLD-TDP, and FTLD-FUS (Kerchner & Rosenbloom, 2014; Honig et al., 2003).

1.  **FTLD-tau:** This category includes diseases caused by *MAPT* mutations as well as sporadic tauopathies like Pick's disease (PiD), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP) (Miki et al., 2016; Schlachetzki, 2011). In these disorders, the tau protein, which normally stabilizes microtubules in neurons, becomes hyperphosphorylated and forms insoluble aggregates. The specific type of tau isoform that aggregates and the morphology of the inclusions differ between these disorders, contributing to their distinct clinical and pathological profiles (Mann, 2010). For instance, PiD is characterized by spherical neuronal inclusions known as Pick bodies (Honig et al., 2003).

2.  **FTLD-TDP:** This is the most common pathology underlying FTLD, found in about 50% of cases (Mann, 2010). It is characterized by inclusions of the TDP-43 protein. Normally, TDP-43 is located in the nucleus and is involved in RNA processing. In FTLD-TDP, the protein is abnormally modified, cleaved, and relocated to the cytoplasm where it forms aggregates (Kerchner & Rosenbloom, 2014). This pathology is associated with mutations in *GRN*, *C9orf72*, *VCP*, and *TARDBP*, as well as a large number of sporadic cases (Mann, 2010).

3.  **FTLD-FUS:** A smaller subset of FTLD cases (around 5-10%) are characterized by inclusions of the FUS protein, another RNA-binding protein with functions similar to TDP-43 (Kerchner & Rosenbloom, 2014; Mann, 2010). FTLD-FUS is typically found in younger-onset patients and is not associated with mutations in the major FTNCD genes (Mann, 2010).

These distinct molecular pathways highlight the complexity of FTNCD. While the clinical syndrome may appear similar, the underlying cellular dysfunction can be quite different. This molecular heterogeneity is a major challenge for the development of disease-modifying therapies, as a drug targeting tau pathology, for example, would not be effective in a patient with FTLD-TDP (Kerchner & Rosenbloom, 2014). Future progress will depend on identifying biomarkers that can accurately predict the underlying molecular pathology in living patients (Kapczinski, 2015).

### Brain Structure and Function

The diagnosis and characterization of FTNCD rely heavily on the assessment of brain structure and function, primarily through neuroimaging and neuropsychological evaluation (Kerchner & Rosenbloom, 2014; Krudop et al., 2021). These methods provide crucial evidence of the focal neurodegeneration that defines the disorder and helps differentiate it from other causes of dementia, such as Alzheimer's disease (AD) or vascular dementia (Arvanitakis et al., 2019; Fontenele et al., 2021).

**Neuroimaging Findings**

Structural and functional neuroimaging are essential tools for diagnosing probable FTNCD (Kerchner & Rosenbloom, 2014). They reveal the characteristic patterns of atrophy and metabolic dysfunction that correspond to the clinical variants.

*   **Structural Imaging (MRI and CT):** Magnetic Resonance Imaging (MRI) is the preferred modality due to its superior soft-tissue contrast (Kuğu et al., 2010). In bvFTNCD, MRI typically demonstrates disproportionate atrophy of the frontal and/or anterior temporal lobes (Kerchner & Rosenbloom, 2014; Honig et al., 2003). The atrophy can be symmetrical but is often more pronounced in the right hemisphere, involving regions like the orbitofrontal, insular, and anterior cingulate cortices (Kerchner & Rosenbloom, 2014; Mahapatra et al., 2016). In the language variants, atrophy is predominantly left-sided. PNFA is associated with atrophy in the left posterior fronto-insular region (Kerchner & Rosenbloom, 2014; Gorno‐Tempini, 2008), while SD shows marked, often "knife-edge," atrophy of the anterior temporal lobes, which can be strikingly asymmetric (Kerchner & Rosenbloom, 2014; Boeve, 2004). In lvPPA, atrophy is typically located in the left posterior temporal and inferior parietal regions (Yoshino, 2011). In the early stages of the disease, however, structural imaging may appear normal or show only subtle, non-specific changes (Schlachetzki, 2011; Espinal et al., 2023), making diagnosis challenging.

*   **Functional Imaging (PET and SPECT):** Functional imaging techniques, such as [F18]-fluorodeoxyglucose positron emission tomography (FDG-PET) and single-photon emission computed tomography (SPECT), can detect abnormalities even before significant atrophy is visible on MRI (Mendez et al., 2007). These techniques measure regional cerebral metabolism or blood flow, respectively. In FTNCD, they reveal patterns of hypometabolism or hypoperfusion that mirror the anatomical distribution of the disease (Kuğu et al., 2010; Szabó & Szabó, 2003). For example, bvFTNCD is characterized by frontal and anterior temporal hypometabolism/hypoperfusion (Kuğu et al., 2010; Grimmer et al., 2004), which helps to differentiate it from AD, where dysfunction is typically centered in the posterior cingulate/precuneus and temporoparietal regions (Arnaldi et al., 2012; Fontenele et al., 2021). Similarly, the PPA variants show distinct patterns of left-hemisphere hypometabolism corresponding to their respective sites of atrophy (Mesulam, 2016; Yoshino, 2011).

**Neuropsychological Profile**

Neuropsychological assessment is critical for documenting the specific pattern of cognitive decline in FTNCD, which is a core diagnostic criterion (Kerchner & Rosenbloom, 2014; Levy & Chelune, 2007). The profile of deficits helps to distinguish FTNCD from other dementias and to classify its clinical subtype (Trivedi, 2006).

*   **Behavioral Variant (bvFTNCD):** The defining cognitive feature of bvFTNCD is a prominent decline in executive abilities (Kerchner & Rosenbloom, 2014; Mendez et al., 2008). Patients show significant impairments on tasks that measure planning, problem-solving, mental flexibility, response inhibition, and abstract reasoning (Bonelli & Cummings, 2007; Otsuki, 2012). This dysexecutive syndrome is often accompanied by deficits in attention and working memory (Kerchner & Rosenbloom, 2014; Miki et al., 2016). Another key area of impairment is social cognition, which includes the ability to recognize emotions, infer the mental states of others (theory of mind), and understand social norms (Shany‐Ur & Rankin, 2011; Mendez, 2022). In contrast, learning and memory for recent events (episodic memory) and perceptual-motor functions are noted to be relatively spared in the early stages, which is a key feature distinguishing bvFTNCD from typical AD (Kerchner & Rosenbloom, 2014; Levy & Chelune, 2007). However, as the disease progresses, memory deficits can emerge (Honig et al., 2003).

*   **Language Variants (PPA):** In all PPA variants, the most prominent deficit is in language ability (Mesulam, 2013; Urazán et al., 2023). In **PNFA**, patients exhibit agrammatism (difficulty with grammar and sentence structure) and apraxia of speech (a motor speech disorder affecting planning and sequencing of movements for speech) (Kerchner & Rosenbloom, 2014; Otsuki, 2015). Phonemic fluency (e.g., naming words that start with 'F') is typically impaired (Kerchner & Rosenbloom, 2014). In **SD**, the core deficits are impaired object naming (anomia) and single-word comprehension (Kerchner & Rosenbloom, 2014; Boeve, 2004). Patients lose knowledge about what words mean and what objects are (Gorno‐Tempini, 2008). They may also show surface dyslexia (difficulty reading irregularly spelled words) and prosopagnosia (impaired recognition of familiar faces) (Kerchner & Rosenbloom, 2014). In **lvPPA**, the primary difficulties are in word-finding (anomia) in spontaneous speech and impaired repetition of sentences and phrases (Yoshino, 2011). Speech is slow and hesitant due to word-finding pauses, and there are frequent phonological errors (sound-based errors) (Maruta et al., 2016). In all PPA variants, other cognitive domains, particularly episodic memory and visuospatial skills, are relatively preserved at onset (Kerchner & Rosenbloom, 2014; Mesulam, 2016).

The combination of characteristic neuroimaging patterns and specific neuropsychological profiles provides a powerful basis for the clinical diagnosis of FTNCD and its subtypes, guiding management and providing prognostic information (Krudop et al., 2021; Vergel Hernández et al., 2021).

### Developmental Neurobiology

Frontotemporal Neurocognitive Disorder is predominantly a disease of mid-to-late adulthood, with a typical age of onset between 45 and 65 years (Kerchner & Rosenbloom, 2014; Kuğu et al., 2010). This late onset contrasts sharply with neurodevelopmental disorders such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability, which are characterized by impairments in brain growth and function that manifest during the developmental period (Patel & Merrick, 2020; Gillberg et al., 2013). While FTNCD is a neurodegenerative process involving the loss of previously acquired functions, neurodevelopmental disorders involve a failure to acquire skills at an age-appropriate rate (Gillberg, 2014; Jan, 2012).

Despite this fundamental distinction, a developmental neurobiology perspective can offer valuable insights into the pathogenesis of FTNCD. The concept of a "neurodevelopmental trajectory" is central to understanding many psychiatric illnesses, such as schizophrenia (Bramon & Murray, 2001; Sawa & Niwa, 2018). In this model, subtle alterations in early brain development, caused by genetic or early environmental factors, create a latent vulnerability that only manifests as clinical illness after further brain maturational events or stressors in adolescence or early adulthood (Dodd, 2007; Howes et al., 2004). Children who later develop schizophrenia often show premorbid signs such as delayed motor and language milestones, subtle cognitive impairments, and poor social functioning (Bramon & Murray, 2001; Isohanni et al., 2005).

It is plausible that a similar long-term vulnerability model may apply to some forms of FTNCD, particularly those with a strong genetic basis (Mann, 2010). Although FTNCD is a late-life disease, the underlying genetic mutations are present from conception (Falk & Moreno, 2019). It is possible that these mutations lead to subtle, subclinical alterations in brain development or synaptic function that create a lifelong vulnerability (Fish, 1977). This vulnerability may not become apparent until the cumulative effects of aging, environmental exposures, or other stressors overwhelm the brain's compensatory mechanisms, leading to the onset of neurodegeneration (Agid & Blin, 2007). For instance, individuals with FTLD pathology may have had subtle, lifelong personality traits or cognitive styles that represent a subclinical manifestation of their genetic risk, analogous to the schizoid or schizotypal traits sometimes seen premorbidly in schizophrenia (Dodd, 2007; Tantam, 1988). However, this remains speculative, as comprehensive longitudinal studies tracking individuals with FTNCD-causing mutations from birth are not available.

The concept of critical periods in development is also relevant (Sarnat, 1987). The brain's plasticity and capacity for reorganization are greatest in early life (Vargha‐Khadem, 2001). A brain insult during a critical period for language or social development can have profound and lasting consequences (Dubovický, 2010; Kavanaugh et al., 2016). In FTNCD, the disease process strikes a mature, fully developed brain. However, the selective vulnerability of specific neural networks—such as the left-hemisphere language network in PPA or the fronto-insular-cingulate networks in bvFTNCD—suggests that these highly evolved, late-maturing circuits may be particularly susceptible to degenerative processes (Schlachetzki, 2011; Bonelli & Cummings, 2007). Adolescence is a critical period for the maturation of prefrontal cortical circuits that are essential for executive function and social cognition (Sawa & Niwa, 2018). It could be hypothesized that subtle inefficiencies in this late developmental process might render these circuits more vulnerable to degeneration decades later.

Furthermore, some genetic syndromes that are considered neurodevelopmental disorders can present with features that overlap with FTNCD. For example, individuals with 22q11.2 deletion syndrome can have cognitive deficits, social impairments, and an extremely high risk of developing psychosis (Tang et al., 2015). While not a model for FTNCD, such syndromes illustrate how genetic defects can disrupt the development of frontal and temporal lobe functions, leading to behavioral and cognitive phenotypes that share features with frontotemporal syndromes (Swillen & McDonald‐McGinn, 2015). Studying these conditions may provide clues about the genes and pathways essential for the long-term maintenance and integrity of these brain regions.

In summary, while FTNCD is a degenerative, not a developmental, disorder, its biological basis may be rooted in lifelong vulnerabilities established by genetic factors. The principles of developmental neurobiology—including developmental trajectories, critical periods, and the late maturation of frontal lobe circuits—provide a valuable framework for generating hypotheses about why specific neural systems are selectively vulnerable in this devastating late-life disease.

### Treatment Mechanisms

Currently, there are no available disease-modifying therapies that can alter, slow, or arrest the underlying neurodegenerative process in FTNCD (Kerchner & Rosenbloom, 2014). Therefore, the management of FTNCD is entirely symptomatic, focusing on controlling the behavioral and psychological manifestations of the disease to improve quality of life for both patients and caregivers (Moretti et al., 2005; Araújo et al., 2013). The biological basis of these interventions lies in modulating the neurotransmitter systems believed to be dysregulated by the frontotemporal lobar degeneration.

**Pharmacological Interventions**

The selection of pharmacological agents is guided by the specific symptom profile of the patient, targeting behaviors such as apathy, disinhibition, agitation, compulsive actions, and mood disturbances (Mendez et al., 2008; Maruta et al., 2016).

*   **Serotonergic Agents:** Given the prominence of compulsive behaviors, impulsivity, and affective dysregulation in bvFTNCD, selective serotonin reuptake inhibitors (SSRIs) are among the most commonly used medications (Moretti et al., 2005). These drugs increase the synaptic availability of serotonin, a neurotransmitter crucial for mood regulation and impulse control (Liu et al., 2019). The rationale for their use is based on the phenomenological overlap between bvFTNCD symptoms and those of obsessive-compulsive disorder (OCD) and impulse control disorders, where SSRIs are a first-line treatment (Murphy et al., 2010; Reid et al., 1997). Studies have shown that SSRIs can be beneficial in reducing behaviors such as disinhibition, irritability, and compulsivity in some FTNCD patients (Moretti et al., 2005; Araújo et al., 2013).

*   **Antipsychotics (Neuroleptics):** Antipsychotic medications, particularly second-generation or "atypical" agents, are often used to manage severe agitation, aggression, and psychotic symptoms like delusions or hallucinations, which can occur in FTNCD (Mendez et al., 2008; Lepping et al., 2015). These drugs primarily act by blocking dopamine D2 receptors, with atypical agents also having effects on serotonin receptors (Dodd, 2007; Ereshefsky et al., 1990). The dopamine hypothesis of psychosis posits that positive symptoms arise from excessive dopaminergic activity in mesolimbic pathways (Dodd, 2007), and blocking these pathways can ameliorate these symptoms (Buckley & Foster, 2014). However, their use in dementia populations is fraught with risk, including increased mortality and cerebrovascular events (Sung & Chang, 2010). Furthermore, because some FTNCD patients develop parkinsonism (Kerchner & Rosenbloom, 2014), dopamine-blocking agents can worsen motor symptoms (Dodd, 2007). Therefore, they must be used with extreme caution and at the lowest effective dose (Grossberg & Manepalli, 1995).

*   **Cholinesterase Inhibitors and Memantine:** These medications, which are standard treatments for Alzheimer's disease (AD), have a limited and controversial role in FTNCD (Rucci & Feinstein, 2014). Cholinesterase inhibitors (e.g., donepezil) work by increasing the availability of acetylcholine, a neurotransmitter important for memory and attention (Arnaldi et al., 2012). While some studies have suggested they might help with apathy or behavioral symptoms, others have found they can worsen agitation and disinhibition in FTNCD patients (Moretti et al., 2005). Their use is generally not recommended unless there is a suspicion of co-occurring AD pathology (Kerchner & Rosenbloom, 2014). Memantine, an NMDA receptor antagonist, has also not shown consistent benefit (Moretti et al., 2005).

*   **Other Agents:** Mood stabilizers, such as anticonvulsants (e.g., valproic acid, carbamazepine), are sometimes used off-label to manage aggression and mood lability, drawing on their established efficacy in bipolar disorder (Reid et al., 1997; Thomas, 2003). Their mechanism is thought to involve the modulation of GABAergic and glutamatergic systems (Hartmann et al., 1993). Stimulants like methylphenidate, which enhance dopamine and norepinephrine transmission, have been explored for the treatment of apathy, but evidence is limited and their potential to worsen agitation is a concern (Dodd, 2007; Moretti et al., 2005).

**Non-Pharmacological Interventions**

Non-pharmacological approaches are the cornerstone of management and should be implemented before or alongside medication (Robinson, 2000). These interventions are based on principles of behavioral modification and environmental adaptation.

*   **Behavioral and Environmental Management:** Structuring the patient's daily routine, reducing environmental stressors (e.g., noise, crowds), and redirecting inappropriate behaviors can be highly effective (Sung & Chang, 2010). For example, managing hyperorality might involve providing access to low-calorie snacks, while compulsive behaviors might be managed by providing a safe outlet for the repetitive action (Moretti et al., 2005). These strategies work by reducing the cognitive and emotional load on a brain with diminished executive and self-regulatory capacity (Bonelli & Cummings, 2007).

*   **Speech and Language Therapy:** For patients with the language variants (PPA), speech and language therapy is the primary intervention (Kerchner & Rosenbloom, 2014; Mesulam, 2013). Therapy aims to preserve existing language skills, teach compensatory strategies (e.g., using communication aids, gestures), and educate family members on how to facilitate communication (Law, 2000). While it cannot reverse the neurodegenerative process, it can help maintain functional communication for as long as possible (Benson & Ardila, 1996).

The ultimate goal for future treatment is the development of therapies that target the underlying molecular pathologies, such as tau aggregation or progranulin deficiency (Jain, 2011). This would require a shift from the current symptomatic approach to one of true disease modification and neuroprotection (Jain, 2019).

### Future Directions

The field of Frontotemporal Neurocognitive Disorder research is rapidly evolving, driven by advances in genetics, molecular biology, and neuroimaging. While significant progress has been made in characterizing the clinical and pathological features of the disorder, numerous fundamental questions remain unanswered, pointing toward critical areas for future investigation (Kerchner & Rosenbloom, 2014).

A primary goal is the development of reliable in vivo biomarkers to diagnose the specific underlying molecular pathology (FTLD-tau, FTLD-TDP, or FTLD-FUS) in individual patients (Kapczinski, 2015; Arnaldi et al., 2012). Current diagnosis relies on clinical syndromes, which have a poor correlation with the underlying proteinopathy (Miki et al., 2016). The ability to accurately identify the molecular subtype in living patients is a prerequisite for the development and testing of targeted, disease-modifying therapies (Kerchner & Rosenbloom, 2014). Future research will likely focus on fluid biomarkers in cerebrospinal fluid (CSF) and blood (e.g., levels of tau, phosphorylated tau, TDP-43, and neurofilament light chain) and advanced molecular imaging techniques, such as PET ligands that can visualize tau or TDP-43 aggregates in the brain (Arnaldi et al., 2012).

Elucidating the fundamental mechanisms of neurodegeneration is another crucial frontier. Research needs to clarify how mutations in genes like *MAPT*, *GRN*, and *C9orf72* lead to the aggregation of specific proteins and subsequent neuronal death (Mann, 2010; Agid & Blin, 2007). Understanding the roles of neuroinflammation, oxidative stress, mitochondrial dysfunction, and lysosomal pathways in FTLD pathogenesis will be essential (Zhang, 2021; Jeon & Kim, 2016; Calingasan et al., 1996). For example, studies on the role of pro-inflammatory cytokines in other neuropsychiatric disorders like depression suggest that immune dysregulation could be a common pathway in brain diseases (Jeon & Kim, 2016; Martone, 2019). Investigating these shared mechanisms across different neurodegenerative and psychiatric conditions may reveal novel therapeutic targets (Hartmann et al., 1993; Robertson et al., 2019).

The development of effective treatments remains the ultimate objective. Future therapeutic strategies will move beyond purely symptomatic management and aim for disease modification (Jain, 2011). This will likely involve a multi-pronged approach, including therapies designed to reduce the production of toxic proteins, prevent their aggregation, or enhance their clearance. Examples could include antisense oligonucleotides to lower the production of abnormal tau, or therapies aimed at boosting progranulin levels in patients with *GRN* mutations. Furthermore, strategies aimed at neuroprotection—that is, preserving neuronal function and preventing cell death in the face of the disease process—are a vital area of research (Jain, 2019; Robertson et al., 2019). Agents that target neuroinflammation, excitotoxicity, or oxidative stress may have a role in slowing disease progression (Volpe, 1997; Zhang, 2021).

Longitudinal studies of at-risk individuals, such as asymptomatic carriers of FTNCD-causing mutations, are critical. Following these cohorts from the presymptomatic stage through the emergence of clinical symptoms will provide invaluable information about the earliest detectable changes in brain structure, function, and cognition (Falk & Moreno, 2019). This will not only refine our understanding of the disease's developmental trajectory but also help define the optimal window for preventive interventions (Sommer & Arango, 2017). Such studies could clarify whether subtle neurodevelopmental differences contribute to the vulnerability to late-life neurodegeneration, a concept well-established in schizophrenia research (Bramon & Murray, 2001; Isohanni et al., 2005).

Finally, there is a pressing need to refine our understanding of the heterogeneity within FTNCD. This includes better characterization of the diverse clinical phenotypes beyond the canonical bvFTNCD and PPA variants, and understanding why a specific genetic mutation or pathology can lead to different clinical syndromes in different individuals (Kerchner & Rosenbloom, 2014; Mann, 2010). Investigating the interplay between genetic background, environmental factors, and comorbid conditions will be key to unraveling this complexity and moving toward a more personalized approach to diagnosis, prognosis, and treatment (Falk & Moreno, 2019; Howes et al., 2004). The integration of clinical, genetic, imaging, and molecular data in large, collaborative studies will be essential to tackling these complex questions and ultimately conquering this devastating group of disorders.

### Conclusion

Major or Mild Frontotemporal Neurocognitive Disorder is a complex and devastating neurodegenerative condition defined by the progressive deterioration of the frontal and temporal lobes. Its clinical presentation, dominated by profound changes in behavior, personality, and language, stands in stark contrast to the memory-led decline of Alzheimer's disease, often leading to diagnostic challenges, particularly in its early stages (Kerchner & Rosenbloom, 2014; Krudop et al., 2021). This chapter has synthesized the current understanding of the biological and neurological underpinnings of FTNCD, drawing exclusively from the provided body of literature.

The heterogeneity of FTNCD is its defining biological characteristic. Clinically, it manifests as distinct syndromes—bvFTNCD and the variants of PPA—which are directly correlated with the specific neuroanatomical regions undergoing atrophy (Kerchner & Rosenbloom, 2014; Mesulam, 2016). BvFTNCD arises from the degeneration of frontal-subcortical circuits, particularly the orbitofrontal and anterior cingulate loops, leading to a dysexecutive syndrome and a loss of social and emotional regulation (Bonelli & Cummings, 2007; Mendez et al., 2008). The language variants result from focal atrophy within the left-hemisphere language network, with distinct patterns of degeneration giving rise to the unique deficits of PNFA, SD, and lvPPA (Mesulam, 2013; Gorno‐Tempini, 2008).

At the molecular level, this clinical heterogeneity is mirrored by a diversity of underlying pathologies, primarily FTLD-tau, FTLD-TDP, and FTLD-FUS (Kerchner & Rosenbloom, 2014; Mann, 2010). A substantial portion of cases are hereditary, with mutations in *MAPT*, *GRN*, and *C9orf72* accounting for the majority of familial disease, each linking to specific protein aggregation pathways (Mann, 2010). The lack of a consistent mapping between clinical syndrome and underlying molecular pathology remains a central challenge in the field, hindering the development of targeted therapies (Miki et al., 2016).

Currently, treatment is confined to symptomatic management, primarily using serotonergic and, with great caution, antipsychotic agents to modulate the behavioral disturbances that cause significant distress to patients and caregivers (Moretti et al., 2005; Araújo et al., 2013). There are no treatments that address the fundamental neurodegenerative process (Kerchner & Rosenbloom, 2014).

Future progress hinges on the development of reliable biomarkers to enable accurate in vivo diagnosis of the underlying pathology, a deeper understanding of the cellular cascades involving inflammation and protein misfolding, and the design of disease-modifying therapies targeting these specific molecular pathways (Jain, 2019; Robertson et al., 2019). The study of presymptomatic individuals at genetic risk offers a crucial window into the earliest stages of the disease, potentially paving the way for preventive strategies (Sommer & Arango, 2017). By continuing to unravel the intricate biological and neurological mechanisms of FTNCD, the scientific community moves closer to transforming this currently untreatable condition into a manageable one.

## References

1. Abdo, C. H. N. (2017). Sexualidade e doenças reumáticas. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2017.16.3.6-12
2. Abdulkareem, M. (2022). Mild intellectual disability among individuals having conduct disorder: a common overlooked issue in forensic psychiatric practice. GLOBAL PSYCHIATRY ARCHIVES. https://doi.org/10.52095/gpa.2022.5378.1057
3. Abdul‐Rahman, O. (2015). Nicolaides-Baraitser Syndrome.
4. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
5. Adam, M. P., Conta, J. H., & Bean, L. J. (2013). Mowat-Wilson Syndrome.
6. Adida, M. (2010). Insight in bipolar disorder. Frontiers in Neuroscience. https://doi.org/10.3389/conf.fnins.2010.12.00009
7. Aerts, A., Batens, K., Santens, P., Mierlo, P. V., Huysman, E., Hartsuiker, R. J., Hemelsoet, D., Duyck, W., Raedt, R., Roost, D. V., & Letter, M. D. (2015). Aphasia therapy early after stroke: behavioural and neurophysiological changes in the acute and post-acute phases. Aphasiology. https://doi.org/10.1080/02687038.2014.996520
8. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
9. Agid, Y., & Blin, J. (2007). Nerve Cell Death in Degenerative Diseases of the Central Nervous System: Clinical Aspects. Novartis Foundation symposium. https://doi.org/10.1002/9780470513422.ch2
10. Ait-El-Mkadem, S., Chaussenot, A., Bannwarth, S., Rouzier, C., & Paquis‐Flucklinger, V. (2015). CHCHD10-Related Disorders.
11. Ajiboye, P., & Yusuf, A. D. (2013). Scientific Letter: Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): A report of two cases. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v16i2.11
12. Akter, R., Kaushik, D., Kumar, K., & Rahman, M. H. (2021). Behavioral Pathophysiology and Psychological Implications for Sleep Disorder in Dementia. https://doi.org/10.1007/978-981-16-4558-7_1
13. Al-Mosawi, A. (2019). Facial Dysmorphism, Mental Retardation, Triphalangeal Toes and Unilateral Renal Agenesis: A New Syndrome. International Invention of Scientific Journal.
14. Alberdi-Páramo, Í., & Pelaz-Antolín, A. (2019). Emocionalidad y temperamento en el trastorno por déficit de atención con o sin hiperactividad. Revista de Neurología. https://doi.org/10.33588/rn.6908.2019032
15. Alecha, M. Á. I., & Rodríguez, M. S. (2008). Procesamiento auditivo en el trastorno específico del lenguaje. Revista de Neurología. https://doi.org/10.33588/rn.46s01.2008007
16. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
17. Alfonso‐Loeches, S., & Guerri, C. (2011). Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408363.2011.580567
18. Alluri, P. R., Solit, J., Leveroni, C. L., Goldberg, K. J., Vehar, J. V., Pollak, L., Colvin, M. K., & Perez, D. L. (2020). Cognitive Complaints in Motor Functional Neurological (Conversion) Disorders: A Focused Review and Clinical Perspective. Cognitive and Behavioral Neurology. https://doi.org/10.1097/wnn.0000000000000218
19. Almada, A. L., Simões, R. M., Constante, M., Casquinha, P., & Heitor, M. J. (2016). Psychogenic stuttering: A case and review. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1389
20. Almannai, M., Dai, H., El‐Hattab, A. W., & Wong, L. C. (2017). FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome.
21. Alvarez, R. (2014). Evaluación de la Disfagia en Niños. Revista GEN.
22. Amer, S. A. M., & Akkad, M. (2016). Correlation between Mild Cognitive Impairment and Functional Status among Elderly. Egyptian Journal of Geriatrics and Gerontology. https://doi.org/10.21608/ejgg.2016.30870
23. Amihăesei, I. C., & Mungiu, O. C. (2012). Posttraumatic stress disorder: neuroendocrine and pharmacotherapeutic approach.. PubMed.
24. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
25. Anand, K. (2016). Revisiting a dilemma: repetitive pain vs. opioid exposures?. Acta Paediatrica. https://doi.org/10.1111/apa.13442
26. Anderson, S. W., Damásio, H., Tranel, D., & Damásio, A. R. (2000). Long-Term Sequelae of Prefrontal Cortex Damage Acquired in Early Childhood. Developmental Neuropsychology. https://doi.org/10.1207/s1532694202anderson
27. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
28. Anticevic, A., Krystal, J. H., & Barch, D. M. (2013). Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches toward understanding cognitive deficits. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139003872.013
29. Apgáua, L. T., & Jaeger, A. (2019). Memory for emotional information and alexithymia A systematic review. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642018dn13-010003
30. Arango, C., Fraguas, D., & Parellada, M. (2013). Differential Neurodevelopmental Trajectories in Patients With Early-Onset Bipolar and Schizophrenia Disorders. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbt198
31. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
32. Araújo, F., Almeida, T. F. D., Rodrigues, J. D., Venâncio, Â., Horta, A., & Lapa, G. (2013). 1963 – Difficulty in the psychopharmacological approach of fronto-temporal dementia- case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76903-7
33. Archer, K. J., & Pammer, K. (2021). Dyslexia. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0029348
34. Archila, R. (2000). Epilepsia y trastornos del aprendizaje. Revista de Neurología. https://doi.org/10.33588/rn.3104.2000284
35. Ardila, A., & Benson, D. F. (1996). Management and Rehabilitation of Aphasia. https://doi.org/10.1093/oso/9780195089349.003.0021
36. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
37. Argilés, J. M., Busquets, S., López‐Soriano, F. J., & Fernández‐Figueras, M. T. (2006). Fisiopatología de la caquexia neoplásica. Nutrición Hospitalaria.
38. Arnaldi, D., Morbelli, S., Morrone, E., Campus, C., & Nobili, F. (2012). Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.. PubMed.
39. Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and Management of Dementia: Review. JAMA. https://doi.org/10.1001/jama.2019.4782
40. Askevold, F. (1977). Predictive value of neuropathic traits. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1977.tb06660.x
41. Assimakopoulos, D., Chalkiadaki, E., Mandrali, T., Tzagaroulakis, A., & Nikolopoulos, T. (2009). Speech and Language Delay: Hearing Loss of Unknown Origin or Manifestation of a Syndrome?. Skull base. https://doi.org/10.1055/s-2009-1224420
42. Avendaño, M. L. P., Rincón, C. M., Tejada, J. V., & Etchepareborda, M. C. (2020). Variantes de neurodesarrollo en pacientes con diagnóstico de agenesia del cuerpo calloso completa y parcial. Revista Neuropsicologia Latinoamericana.
43. Axelrod, B. N. (2008). Fabrication of psychiatric symptoms: Somatoform and psychotic disorders. Psychology Press eBooks. https://doi.org/10.4324/9780203890042-23
44. Balint, B., Damásio, J., Magrinelli, F., Guerreiro, R., Brás, J., & Bhatia, K. P. (2020). Psychiatric Manifestations of <scp><i>ATP13A2</i></scp> Mutations. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13034
45. Balkan, E. (2023). Initial Approach to Patients with Balance Disorders. IntechOpen eBooks. https://doi.org/10.5772/intechopen.111837
46. Ball, M. J. (2021). An Introduction to Speech Disorders. Routledge eBooks. https://doi.org/10.4324/9780429320903-6
47. Bandelow, B., Baldwin, D. S., Abelli, M., Bolea-Alamañac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., Grünblatt, E., Jarema, M., Kim, Y., Maron, E., Masdrakis, V., Mikova, O., Nutt, D., Pallanti, S., Pini, S., ... Riederer, P. (2016). Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2016.1190867
48. Barbosa, M. O. S., Silva, F. L. C., Castro, J. D. O., Marino, L. D. B., Silva, V. D. S., Pinho, R. C., & Bonfim, Y. C. (2018). PROCESSO DE ENFERMAGEM EM PACIENTE COM ESQUIZOFRENIA HEBEFRÊNICA: UM RELATO DE CASO. 13º Congresso Internacional Rede Unida.
49. Barea, M. V., Solis, M., Sempere, E. P., Luque, M. O., & Paris, J. S. (2022). Language disorders or mild cognitive disorder. About a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1685
50. Barker, R. A., & Redfern, C. (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
51. Barliana, M., Laksono, J., Sumirtanurdin, R., Dania, H., Ramadhani, F., Perwitasari, D., & Abdulah, R. (2019). Polymorphism of TPH2 gene rs120074175 is not associated with risk factors of schizophrenia. Journal of Pharmacy And Bioallied Sciences. https://doi.org/10.4103/jpbs.jpbs_216_19
52. Barrett, A. M. (2010). Rose-colored answers: neuropsychological deficits and patient-reported outcomes after stroke.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.3233/ben-2009-0250
53. Barry, S., Baird, G., Lascelles, K., Bunton, P., & Hedderly, T. (2011). Neurodevelopmental movement disorders - an update on childhood motor stereotypies. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04058.x
54. Basuta, K., Schneider, A., Gane, L. W., Polussa, J., Woodruff, B. K., Pretto, D., Hagerman, R. J., & Tassone, F. (2015). High functioning male with fragile X syndrome and fragile X‐associated tremor/ataxia syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.37125
55. Beck, A. T., & Bredemeier, K. (2016). A Unified Model of Depression. Clinical Psychological Science. https://doi.org/10.1177/2167702616628523
56. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
57. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
58. Begué, N. M., Cobos, E., Quiñones, S. M., & Ginebreda, J. A. (2011). Alteraciones morfologícas del disco óptico. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears.
59. Belagaje, S., & Bonomo, J. (2012). A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000138
60. Beninger, R. J. (2018). Life's rewards. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198824091.001.0001
61. Benoit, C., Svahn, J., Debs, R., Vandendries, C., Lenglet, T., Zyss, J., Maisonobe, T., & Viala, K. (2021). Focal chronic inflammatory demyelinating polyradiculoneuropathy: Onset, course, and distinct features. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.12438
62. Benson, C., & Lusardi, P. (1995). Neurologic Antecedents to Patient Falls. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-199512000-00003
63. Beran-Koehn, M. A., Zupanc, M. L., Patterson, M. C., Olk, D. G., & Ahlskog, J. E. (2000). Violent recurrent ballism associated with infections in two children with static encephalopathy. Movement Disorders. https://doi.org/10.1002/1531-8257(200005)15:3<570::aid-mds1022>3.0.co;2-f
64. Berk, M., Post, R. M., Ratheesh, A., Gliddon, E., Singh, A., Vieta, E., Carvalho, A. F., Ashton, M. M., Berk, L., Cotton, S., McGorry, P. D., Fernandes, B. S., Yatham, L. N., & Dodd, S. (2017). Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. https://doi.org/10.1002/wps.20441
65. Besag, F., Gobbi, G., Aldenkamp, A. P., Caplan, R., Dunn, D. W., & Sillanpää, M. (2016). Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Subtle behavioural and cognitive manifestations of epilepsy. Epileptic Disorders. https://doi.org/10.1684/epd.2016.0816
66. Bhattacharya, K. (2015). Cognitive Function in Schizophrenia: A Review. African Journal of Psychiatry. https://doi.org/10.4172/psychiatry.1000187
67. Bielefeldt, K., Tuteja, A. K., & Nusrat, S. (2016). Disorders of gastrointestinal hypomotility. F1000Research. https://doi.org/10.12688/f1000research.8658.1
68. Bigio, M. R. D. (2021). Neuronal Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.030
69. Bill, J. (2012). Pharmacological Neuromodulation in Autism Spectrum Disorders. InTech eBooks. https://doi.org/10.5772/28670
70. Binder, L. M., Spector, J. J., & Youngjohn, J. R. (2012). Psychogenic Stuttering and Other Acquired Nonorganic Speech and Language Abnormalities. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acs051
71. Biswas, A. B., & Bhaumik, S. (2015). Self‐Injurious Behaviour. https://doi.org/10.1002/9781118897164.ch13
72. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
73. Blair, J. (2019). Dysfunctional neurocognition in individuals with clinically significant psychopathic traits. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2019.21.3/rblair
74. Blankfield, A. (2013). Article Commentary: Kynurenine Pathway Pathologies: Do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). International Journal of Tryptophan Research. https://doi.org/10.4137/ijtr.s11193
75. Blok, A., Verduyn, T. J., Vergouwen, A. C. M., & Weinstein, H. C. (2005). [Disorders of concentration and memory in young adults and middle-aged persons]..
76. Blythe, S. G., Beuret, L. J., Blythe, P., & Scaramella-Nowinski, V. (2017). The Significance of Primitive and Postural Reflexes. https://doi.org/10.1002/9781119164746.ch2
77. Boberg, E., & Webster, W. G. (1990). Stuttering: current status of theory and therapy.. PubMed.
78. Boeve, B. F. (2004). Asymmetric cortical degeneration syndrome: semantic dementia. https://doi.org/10.1093/oso/9780195177442.003.0001
79. Bonelli, R. M., & Cummings, J. L. (2007). Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2007.9.2/rbonelli
80. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2017). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.5281/zenodo.4681378
81. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2020). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.17605/osf.io/5z9c4
82. Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., & Foster, N. L. (2001). Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss. Archives of Neurology. https://doi.org/10.1001/archneur.58.3.411
83. Brame, A., & Singer, M. (2010). Stressing the obvious? An allostatic look at critical illness. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e3181f23e92
84. Bramon, E., & Murray, R. (2001). A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2001.3.4/ebramon
85. Bransfield, R. C., & Friedman, K. J. (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
86. Brinker, D., Śmiłowska, K., Paschen, S., Antonini, A., Moro, E., & Deuschl, G. (2023). How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13962
87. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
88. Broers, D. (2010). Patiënten met ongewone extractiewensen 2. Wilsonbekwaamheid en psychopathologische oorzaken. Nederlands Tijdschrift voor Tandheelkunde. https://doi.org/10.5177/ntvt.2010.11.10121
89. Bronstein, A. M., & Lempert, T. (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
90. Bruna, O., Signo, S., & Subirana-Mirete, J. (2011). Llenguatge i envelliment: una visió des de la neuropsicologia. Aloma: revista de psicologia, ciències de l'educació i de l'esport Blanquerna.
91. Brust, J. C. (1999). Substance Abuse, Neurobiology, and Ideology. Archives of Neurology. https://doi.org/10.1001/archneur.56.12.1528
92. Brüne, M. (2008). Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199207688.003.0009
93. Buck, K. D., Leonhardt, B. L., George, S., James, A. V., Vohs, J. L., & Lysaker, P. H. (2017). M42. Metacognitive Deficits in Schizophrenia; Comparisons With Borderline Personality Disorder and Substance Use Disorder. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbx022.040
94. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
95. Budka, H., Aguzzi, A., Brown, P., Brucher, J., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J., Ironside, J. W., Jellinger, K. A., Kretzschmar, H. A., Lantos, P. L., Masullo, C., Schlote, W., Tateishi, J., & Weller, R. O. (1995). Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases). Brain Pathology. https://doi.org/10.1111/j.1750-3639.1995.tb00625.x
96. Budson, A. E., & O’Connor, M. K. (2021). Which medications can improve thinking, memory, behavior, or function?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0013
97. Bueno, B. B., Soares, V. S., & Oliveira, C. F. D. (2014). Patologias associadas à deficiências na síntese do grupo heme. Revista Científica da FHO|Uniararas. https://doi.org/10.55660/revfho.v2i2.101
98. Burgess, A. W., Hartman, C. R., & Clements, P. T. (1995). Biology of Memory and Childhood Trauma. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19950301-04
99. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
100. Caetano, F., Araújo, M., Samouco, A., & Carvalho, S. (2021). 518 - AUTOIMMUNE DEMENTIA – WHEN TO SUSPECT?. International Psychogeriatrics. https://doi.org/10.1017/s1041610221002131
101. Calingasan, N. Y., Sheu, K. R., Baker, H., Gandy, S., & Gibson, G. E. (1996). Thiamine Deficiency as a Model of Selective Neurodegeneration with Chronic Oxidative Deficits. Neurodegenerative Diseases. https://doi.org/10.1007/978-1-4899-0209-2_25
102. Camilleri, M. (2005). Mechanisms in IBS: something old, something new, something borrowed…. Neurogastroenterology & Motility. https://doi.org/10.1111/j.1365-2982.2004.00632.x
103. Campuzano, T. M., Calderón, T. Z., & Tircio, C. N. (2021). DEGLUCIÓN ATÍPICA CONSIDERADA COMO FACTOR PREDISPONENTE PARA LA MALOCLUSIÓN PRESENTE EN NIÑOS CON DENTICIÓN TEMPORAL O MIXTA. Revista Científica Especialidades Odontológicas UG. https://doi.org/10.53591/eoug.v1i2.17
104. Canapathy, M., Kurushev, J., Chitra, F., & Dash, M. (2019). Impact of Sensory Deprivation on Health Outcome. Acta Scientific Paediatrics. https://doi.org/10.31080/aspe.2019.02.0165
105. Candura, S. M., & Scelsi, R. (2013). [Occupational toxic neuropathies: morphology in peripheral nerve biopsies].. PubMed.
106. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
107. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
108. Caruso, G. M., & Kertay, L. (2019). Part I: Psychological Factors in Delayed and Failed Recovery and Unnecessary Disability. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2019.mayjun01
109. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
110. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
111. Castillo-Villanueva, E., Coy, P. E. C., Shejet, F. O., Durán, E. T., & Cabrera, D. M. (2010). Evaluación de funciones cognitivas: atención y memoria en pacientes con trastorno de pánico. Salud Mental.
112. Celińska‐Löwenhoff, M., & Musiał, J. (2013). [Psychiatric manifestations of autoimmune diseases--diagnostic and therapeutic problems].. PubMed.
113. Ceravolo, F., Sestito, S., Falvo, F., Salpietro, V., Polizzi, A., Ruggieri, M., Bruno, M., & Concolino, D. (2016). Neurological Involvement in Inherited Metabolic Diseases: An Overview. Journal of Pediatric Biochemistry. https://doi.org/10.1055/s-0036-1582235
114. Chandran, S. A. (2013). A Study of Cognitive Functioning in Aging.
115. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
116. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
117. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
118. Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003). Pediatric Stress: Hormonal Mediators and Human Development. Hormone Research in Paediatrics. https://doi.org/10.1159/000069325
119. Chelimsky, G., & Chelimsky, T. (2003). Evaluation and Treatment of Autonomic Disorders of the Gastrointestinal Tract. Seminars in Neurology. https://doi.org/10.1055/s-2004-817729
120. Chen, Y., Garcia, G. E., Huang, W., & Constantini, S. (2014). The Involvement of Secondary Neuronal Damage in the Development of Neuropsychiatric Disorders Following Brain Insults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00022
121. Chevallier, B., & Refinetti, P. (2020). [Dangerous practices and games at school].. PubMed.
122. Chicharro-Ciuffardi, A., González-Silva, M., Marinis-Palombo, A. D., & Gabler-Santalices, G. (2012). Psychiatric disorders secondary to nonconvulsive status epilepticus of frontal origin. Two clinical case reports.. PubMed.
123. Chiu, M. (2007). [Memory and memory disorders].. PubMed.
124. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
125. Chughtai, B., Sciullo, D., Khan, S. A., Rehman, H., Mohan, E., & Rehman, J. (2009). etiology, diagnosis & management ofHypersexuality: a review. The Internet Journal of Urology.
126. Cianchetti, C., Pruna, D., & Ledda, M. (2013). Epileptic seizures and headache/migraine: A review of types of association and terminology. Seizure. https://doi.org/10.1016/j.seizure.2013.05.017
127. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. II. Stress and distress.. PubMed.
128. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. III. An overview of assessment.. PubMed.
129. Coghill, D., Bonnar, S., Duke, S. E., Graham, J., & Seth, S. G. (2009). Pre-school problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0006
130. Cohen, A. S. A., & Gibson, W. T. (2019). EED-Related Overgrowth.
131. Cooper, L., Copeland, S., Dailey, S., Downey, D., Petersen, M. C., Stimson, C., & Dyke, D. C. V. (2008). Feeding and swallowing dysfunction in genetic syndromes. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.19
132. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
133. Couser, N. L., Masood, M. M., Aylsworth, A. S., & Stevenson, R. E. (2017). Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genetics. https://doi.org/10.1080/13816810.2016.1247459
134. Creten, C., Zwaan, S. V. D., Blankespoor, R. J., Maatkamp, A., Klinkenberg, S., Kranen‐Mastenbroek, V. H. V., Nicolai, J., Dhossche, D. M., Os, J. V., & Schieveld, J. N. M. (2012). [Anti-NMDA-receptor encephalitis: a new axis-III disorder in the differential diagnosis of childhood disintegrative disorder, early onset schizophrenia and late onset autism].. PubMed.
135. Crevier‐Buchman, L. (2007). Speech therapy before and after phonosurgery.
136. Cristina, L., Făget, D., Chiriță, V., Chiriță, R., & Manea, M. (2019). "Alternative therapies and management of dementia in Alzheimer's disease". Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.04.07
137. Crnic, K., Todorović, M., Marković, S., Kastratović, D., & Timotijevic, I. (2016). Addiction and depression comorbidity approaches. Hospital Pharmacology - International Multidisciplinary Journal. https://doi.org/10.5937/hpimj1603440c
138. Cummings, J. L. (1995). Anatomic and Behavioral Aspects of Frontal‐Subcortical Circuitsa. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1995.tb38127.x
139. Cummings, J. L. (1999). Principles of neuropsychiatry: Towards a neuropsychiatric epistemology. Neurocase. https://doi.org/10.1080/13554799908402723
140. Cummings, J. L. (1999). Principles of Neuropsychiatry: Towards a Neuropsychiatric Epistemology. Neurocase. https://doi.org/10.1093/neucas/5.3.181
141. Cummings, J. L., Devanand, D. P., & Stahl, S. M. (2020). Dementia-related psychosis and the potential role for pimavanserin. CNS Spectrums. https://doi.org/10.1017/s1092852920001765
142. Cüreoǧlu, S., FUKUSHIMA, H., Schachern, P. A., Paparella, M. M., & HARADA, T. (2005). The Effects of Type 2 Diabetes Mellitus on the Cochlear Structure in Human Temporal Bones. Otolaryngology. https://doi.org/10.1016/j.otohns.2005.05.545
143. Dalen, J. W. V., Charante, E. P. M. V., Nederkoorn, P. J., Gool, W. A. V., & Richard, E. (2013). Poststroke Apathy. Stroke. https://doi.org/10.1161/strokeaha.112.674614
144. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
145. Danasekaran, R., Annadurai, K., & Mani, G. (2014). The need to create awareness about autism. International Journal of Contemporary Pediatrics. https://doi.org/10.5455/2349-3291.ijcp20140519
146. Davidescu, E. I., Tudose, C., Popa, N. L., & Chirila, M. (2015). Frontotemporal Neurocognitive Disorder: a Challenging Diagnosis. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30969-x
147. Dawson, S., Jordan, Z. A., & Attard, M. (2012). Carersʼ experiences of seeking help for relatives with first-episode psychosis: a systematic review of qualitative evidence.. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201210561-00009
148. Dehelean, L., Marinescu, I., Stovicek, P. O., & Andor, M. (2019). Cardiovascular anomalies and evolutionary risk factors in schizophrenia - multifactorial approach.. PubMed.
149. Delattre, J., Moll, J., Antoine, J. C., Brashear, H. R., Drlicek, M., Dropcho, E. J., Giometto, B., Graus, F., Greenlee, J., Honnorat, J., Jaeckle, K. A., Tanaka, K., & Vecht, C. (1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology. https://doi.org/10.1212/wnl.45.10.1937
150. Delgado, S., Wassenaar, E., & Strawn, J. R. (2011). Does Your Patient Have a Psychiatric Illness or Nonverbal Learning Disorder? Clinical Clues Help Differentiate Overlapping Symptoms and Syndromes. Current psychiatry.
151. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
152. Demi̇rci̇, E. (2023). Emotional Intelligence in Female Children with PTSD After Sexual Abuse. Eurasian Journal of Medicine and Oncology. https://doi.org/10.14744/ejmo.2023.59555
153. Deriaz, N., Willi, J., Orihuela-Flores, M., & Carminati, G. G. (2008). PERVASIVE DEVELOPMENTAL DISORDERS, AGGRESSIVE BEHAVIOUR AND SEIZURES: A CASE REPORT.
154. Devi, S. B. (2017). Effectiveness of Progressive Resistance Training for theChildren with Spastic Diplegic Cerebral Palsy: A ControlledExperimental study.
155. Dhingra, L., Ahmed, E., Shin, J. G., Scharaga, E., & Magun, M. (2015). Cognitive Effects and Sedation. Pain Medicine. https://doi.org/10.1111/pme.12912
156. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
157. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
158. Dieterich, C. A., Snyder, N. D., & Villani, C. J. (2016). A legal study of children with emotional disturbance and mental health needs and implications for practice.. The Journal of Law of Education.
159. Dma, M. (2010). The genetics and molecular pathology of frontotemporal lobar degeneration. CRC Press eBooks. https://doi.org/10.1201/b13196-89
160. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
161. Domingos, A., Silva, V., Correia, C., Rocha, L., Costa, T., Faria, M., & Mota, M. C. (2021). MO1023BARDET-BIEDL SYNDROME OR SENIOR-LOKEN SYNDROME? GOING BEYOND THE OBVIOUS. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfab108.0020
162. Domoto‐Reilly, K., Sapolsky, D., & Dickerson, B. C. (2014). Mild Cognitive Impairment (MCI) Stage of the Frontotemporal Dementias: Early Diagnosis and Management. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.57
163. Domínguez, C., Uribe, M. S. G., & Roncero, C. Í. (2010). Trastorno del Espectro Autista y Esquizofrenia. Revista de Psiquiatría Infanto-Juvenil.
164. Domínguez, L. N., Martin, P. R., Olea, A. M., Martínez, N. B., Sanjosé, G. U., González, M. M., & Tolosa-Delgado, A. (2016). Atypical Psychotic Symptoms in Lafora´s Disease: A Case Report.
165. Dorahy, M. J. (2022). Subjective Amnesia in Dissociative Identity Disorder. Routledge eBooks. https://doi.org/10.4324/9781003057314-48
166. Doskas, T., Vavougios, G. D., Karampetsou, P., Kormas, C., Synadinakis, E., Stavrogianni, K., Sionidou, P., Serdari, A., Vorvolakos, T., Iliopoulos, I., & Vadikolias, Κ. (2021). Neurocognitive impairment and social cognition in multiple sclerosis. International Journal of Neuroscience. https://doi.org/10.1080/00207454.2021.1879066
167. Dubois, B., Pillon, B., & Agid, Y. (1996). Testing cognition may contribute to the diagnosis of movement disorders. Neurology. https://doi.org/10.1212/wnl.46.2.329
168. Dubovický, M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdisciplinary Toxicology. https://doi.org/10.2478/v10102-010-0012-4
169. Duffard, A. M. E. D., & Duffard, R. (1996). Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.. Environmental Health Perspectives. https://doi.org/10.1289/ehp.96104s2353
170. Durukan, İ., Tufan, A. E., & Türkbay, T. (2009). Risperidone Treatment May Benefit Childhood Disintegrative Disorder: Presentation of Two Cases. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology.
171. Dégeilh, F., Viard, A., Dayan, J., Guenolé, F., Egler, P., Baleyte, J., Eustache, F., & Guillery‐Girard, B. (2013). Memory impairment in post-traumatic stress disorder: Behavioral and neuroimaging findings. Revue de neuropsychologie.
172. D’Amico, A., & Bertini, E. (2019). Neonatal Hypotonia. Neurology. https://doi.org/10.1016/b978-0-323-54392-7.00013-3
173. Edwards, J. G. (1995). Depression, antidepressants, and accidents. BMJ. https://doi.org/10.1136/bmj.311.7010.887
174. Eizaguirre, A. E. (2007). Impulsividad en la bulimia nerviosa y psicoterapia dinámica.. Cuadernos de terapia familiar.
175. Elkan, E.-M., Papuc, A.-M., Goroftei, R. E. B., Banu, E. A., Zlati, M. L., Albeanu, A. G., & Pleșea-Condratovici, A. (2023). DREAMING AND PARASOMNIAS FROM A CEREBRAL STRUCTURAL VIEW. https://doi.org/10.35630/2022/12/psy.ro.6
176. Erbguth, F. (2019). [Acute Disorders of Consciousness and Coma - Systematics, Differential Diagnosis and Management].. DMW - Deutsche Medizinische Wochenschrift.
177. Ereshefsky, L., Tran-Johnson, T., & Watanabe, M. (1990). Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics.. PubMed.
178. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
179. Esmonde, T., Giles, E., Xuereb, J. H., & Hodges, J. R. (1996). Progressive supranuclear palsy presenting with dynamic aphasia.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.60.4.403
180. Espay, A. J. (2009). Frontal Lobe Disorders. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0021405
181. Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., LaFaver, K., LaFrance, W. C., Lang, A. E., Nicholson, T. R., Nielsen, G., Reuber, M., Voon, V., Stone, J., & Morgante, F. (2018). Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2018.1264
182. Espinal, E., Erani, F., & Minniti, N. (2023). A - 39 Diagnosing Behavioral Variant Frontotemporal Dementia in the Absence of Notable Cognitive Changes: the Value of Collateral Reports. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acad067.056
183. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
184. Esteves-Sousa, D., Albuquerque, M., Facucho-Oliveira, J., Santos, P. E. D., Costa, M. S., Chai, M. V., Mendonça, L., & Tropa, J. (2019). ANTIPSYCHOTIC AGENTS, UNDERNEATH THEIR ACTION – STRENGTHS AND SHORTCOMINGS. https://doi.org/10.26226/morressier.5d1a037657558b317a14069b
185. Ettinger, U., Möhr, C., Gooding, D. C., Cohen, A. S., Rapp, A. M., Haenschel, C., & Park, S. (2015). Cognition and Brain Function in Schizotypy: A Selective Review. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbu190
186. Evans, D., Levene, M. I., & Tsakmakis, M. (2007). Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd001240.pub2
187. Fabré, L. A., Valdés, R. F. R., & Pupo, M. E. C. (2005). Funciones cognitivas y Epilepsia. DOAJ (DOAJ: Directory of Open Access Journals).
188. Fadl, A. A. S., Alharthi, S. M. S., Aldhneen, B. A. A., Alahdal, S. M. A., Abdulrahim, N. M. F., Alotaibi, N. A. S., Samti, A. I. M. A., Alharthi, A. E. M., Aljabri, F. A. Y., & Alrsheed, N. R. A. (2021). A Review on Pediatric Social Phobia and Selective Mutism. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2021/v33i48b33279
189. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
190. Farah, M. J., & Feinberg, T. E. (2005). Patient-Based Approaches to Cognitive Neuroscience. https://doi.org/10.7551/mitpress/5268.001.0001
191. Farinde, A. (2013). Psychotic Disorders and the use of Antipsychotic Medications: A Review. Deleted Journal.
192. Fatima, K., Mehendale, A. M., & Reddy, H. (2022). Young-Onset Dementia and Neurodegenerative Disorders of the Young With an Emphasis on Clinical Manifestations. Cureus. https://doi.org/10.7759/cureus.30025
193. Faustino, B. (2021). Neurocognition applied to psychotherapy: A brief theoretical proposal based on the complex neural network perspective. Applied Neuropsychology Adult. https://doi.org/10.1080/23279095.2021.1883615
194. Feldtmann, E., Pointdujour, P., Bellido, C., & Preuss, C. (2023). Diagnosis and Management of Social Anxiety Disorder. CRC Press eBooks. https://doi.org/10.1201/9781003333821-3
195. Felipe, L. (2019). Central Auditory Processing Deficits in the Elderly. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2019.03.000654
196. Fenn, J., Lorde, N., Ward, J. M., & Borovickova, I. (2021). Hypophosphatasia. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2021-207426
197. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker od neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/000298292014238
198. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039822014238
199. Ferrari, M., Silva, J. A., Leong, G., & Weinstock, R. (1997). The Role of Mania in the Genesis of Dangerous Delusional Misidentification. Journal of Forensic Sciences. https://doi.org/10.1520/jfs14179j
200. Ferreira, B. R., & Jafferany, M. (2021). Classification of psychodermatological disorders. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.14112
201. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
202. Figueira, M. L. (2010). Are depressive residual symptoms independent of treatments?. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-9-s1-s72
203. Fiori, P., Monaco, A., & Luigi, M. G. (2010). Brief assessment of negative dysmorphic signs. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s13005
204. Fish, B. (1977). Neurobiologic Antecedents of Schizophrenia in Children. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1977.01770230039002
205. Fitten, L. J. (2015). Psychological Frailty in the Aging Patient. Nestlé Nutrition Institute Workshop series. https://doi.org/10.1159/000382060
206. Fitó, A. S., Roura, R. C., López‐Sala, A., Lluch, C. B., López, J. M., Rebollo, M., Julià, M. G., Póo, L. C., & Plana, J. C. (2011). Amnesia del desarrollo como secuela cognitiva focal de patología neonatal. Revista de Neurología. https://doi.org/10.33588/rn.52s01.2010803
207. Fontenele, J. L., Moura, C. G. F., & Oliveira, G. D. P. (2021). Clinical and radiological features of main dementias. Revista Brasileira de Neurologia.
208. Fowler, N. R., Gao, S., Frame, A., Perkins, A. J., Monahan, P. O., & Boustani, M. (2011). P2‐432: Who refuses diagnostic assessment for dementia?. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2011.05.1305
209. Franco, P., Kugener, B., Dijoud, F., Scaillet, S., Groswasser, J., Kato, I., Montemitro, E., Lin, J., & Kahn, A. (2007). Sudden Infant Death Syndrome from Epidemiology to Pathophysiology. Current Pediatric Reviews. https://doi.org/10.2174/157339607781369528
210. Frye, C. A., Paris, J. J., Osborne, D. M., Campbell, J. C., & Kippin, T. E. (2011). Prenatal Stress Alters Progestogens to Mediate Susceptibility to Sex-Typical, Stress-Sensitive Disorders, such as Drug Abuse: A Review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2011.00052
211. Furr, M., & Reed, S. M. (2015). Examination of the Nervous System. https://doi.org/10.1002/9781118993712.ch6
212. Gallego, D., Figueroa, J., & Orozco, C. (2010). Síndrome de disfunción cognitiva de perros geriátrico. Revista Mvz Córdoba. https://doi.org/10.21897/rmvz.313
213. Garcia, C. P., Sacks, S. A., & Mamani, A. G. W. D. (2012). Neurocognition and Cognitive Biases in Schizophrenia. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0b013e3182614264
214. García, G. G., & Coderch, J. (2011). ¿El deterioro cognitivo en los primeros episodios de esquizofrenia es generalizado o selectivo?. Alzheimer Realidades e investigación en demencia. https://doi.org/10.5538/1137-1242.2011.48.18
215. Garozzo, M. T., Caruso, D., Mendola, F. M. C. L., Nora, A. D., Romano, K., Leonardi, R., Falsaperla, R., Zanghì, A., & Praticò, A. D. (2021). SYNGAP1 and Its Related Epileptic Syndromes. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0041-1727144
216. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
217. Garriga-Grimau, L., Laín, G. A., Nascimiento, M. T., & Aleman, A. P. (2015). Síndrome cerebeloso cognitivo-afectivo. Archivos Argentinos de Pediatria. https://doi.org/10.5546/aap.2015.e268
218. Gavrin, J. R., & Chapman, C. R. (1995). Suffering and the Dying Patient. Journal of Pharmaceutical Care in Pain & Symptom Control. https://doi.org/10.1300/j088v03n03_05
219. Genovese, E., Vallarino, M., & Farneti, D. (2010). AAC in communication disorders. Audiological Medicine. https://doi.org/10.3109/1651386x.2010.530024
220. Ghanemi, A. (2013). Neurotransmitters' Activity and Pharmacotherapies: From Decision Making Process to Juridical Implications. International Journal of Advances in Applied Sciences. https://doi.org/10.11591/ijaas.v2.i3.pp137-140
221. Ghetti, B., Murrell, J. R., Boyer, P. J., Piccardo, P., Vidal, R., Hargrave, K., Scott, K. R., Silber, M. H., Filley, C. M., DeMasters, B. K., Iyriboz, T., & Towfighi, J. (2012). P4‐090: Early‐onset Alzheimer's disease associated with PSEN1 L166P mutation: An atypical clinical phenotype. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.1792
222. Ghosh, S. (2015). Better understanding of etiopathology needed to develop novel treatments. Medicus.
223. Gi, S. (2011). [Neurophysiological and neurotransmitter mechanisms of behavior inhibition in normal and pathological conditions]..
224. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
225. Giazkoulidou, A., Messinis, L., & Nasios, G. (2019). Cognitive functions and social cognition in multiple sclerosis: An overview.. PubMed.
226. Gil, J. S. L., Tapia, E. E., Loyola, M. A. A., & Castillo, J. M. C. (2013). Afasia motora transitoria por encefalopatía hipóxica: papel de la ínsula. Anales Médicos de la Asociación Médica del Centro Médico ABC.
227. Gillberg, C. (1995). Neuorodevelopmental examination of the child with neuropsychiatric problems. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511570094.016
228. Gillberg, C. (2014). [ESSENCE gathers the diagnoses into a whole].. PubMed.
229. Gillberg, C. (2014). [Not Available].. PubMed.
230. Gillberg, C., Fernell, E., & Minnis, H. (2013). Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations. The Scientific World JOURNAL. https://doi.org/10.1155/2013/710570
231. Goel, P., Khurshid, A., Sharma, M., Irshad, N., Chachra, S., & Dhindsa, A. (2020). Psychological development: milestones from birth to adolescent. International Journal of Indian Psychology. https://doi.org/10.25215/0802.056
232. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
233. Gonem, S. (2017). Constipation. CRC Press eBooks. https://doi.org/10.4324/9781315383798-18
234. Gonem, S. (2017). Dysphagia. CRC Press eBooks. https://doi.org/10.4324/9781315383798-16
235. Gonzalez, C. H., Sommer, A., Meisner, L. F., Elejalde, B. R., Opitz, J. M., & Francke, U. (1977). The trisomy 4p syndrome: Case report and review. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.1320010202
236. Gonçalves, M. R. R., Capelli, L., Nitríni, R., Barbosa, E. R., Porto, C. S., Lucato, L. T., & Vianna‐Morgante, A. M. (2007). ATYPICAL CLINICAL COURSE OF FXTAS: RAPIDLY PROGRESSIVE DEMENTIA AS THE MAJOR SYMPTOM. Neurology. https://doi.org/10.1212/01.wnl.0000262058.68100.ea
237. Gordon, M. L., Doghramji, P. P., & Lieberman, J. A. (2007). Stay Awake! Understanding, Diagnosing, and Successfully Managing Narcolepsy. Current psychiatry.
238. Gorson, K. C., & Gooch, C. L. (2015). The (mis)diagnosis of CIDP. Neurology. https://doi.org/10.1212/wnl.0000000000001838
239. Grajales, D. V. (2019). La posesión demoníaca: psicosis, neurosis histérica o trastorno neuropsicológico. Poiésis. https://doi.org/10.21501/16920945.3198
240. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
241. Grasso, M., Piscopo, P., Confaloni, A., & Denti, M. A. (2011). 17 Neurodegenerative Disorders. Georg Thieme Verlag eBooks. https://doi.org/10.1055/b-0034-75424
242. Graz, M. B., Newman, C. B., & Borradori-Tolsa, C. (2014). Devenir et prise en charge des enfants grands prématurés. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2014.10.418.0450
243. Greden, J. F., Dilsaver, S. C., & Snider, R. M. (1987). Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-198701000-00001
244. Greene, J. G., & Bone, I. (2007). Understanding Neurology: A Problem-Oriented Approach.
245. Gregory, A., Kurian, M. A., Haack, T. B., Hayflick, S. J., & Hogarth, P. (2017). Beta-Propeller Protein-Associated Neurodegeneration.
246. Grieco, J. A., Pulsifer, M. B., Seligsohn, K., Skotko, B. G., & Schwartz, A. (2015). Down syndrome: Cognitive and behavioral functioning across the lifespan. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31439
247. Grisold, W., Vass, A., Schmidhammer, R., & Zifko, U. (2007). Rehabilitation of Neuropathies. Critical Reviews in Physical and Rehabilitation Medicine. https://doi.org/10.1615/critrevphysrehabilmed.v19.i1.20
248. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
249. Grossberg, G. T., & Manepalli, J. (1995). The older patient with psychotic symptoms. Psychiatric Services. https://doi.org/10.1176/ps.46.1.55
250. Groth, M., Much, C., & Fiehler, J. (2013). Manifestation of Acute Leriche Syndrome as Cauda Equina Syndrome. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-0032-1330431
251. Grozlekova, L. S., & Koeva, Y. (2019). EXPERIMENTAL MODEL OF SCHIZOPHRENIA AND MORPHOLOGICAL CHANGES IN BRAIN. Trakia Journal of Sciences. https://doi.org/10.15547/tjs.2019.s.02.013
252. Guessoum, S. B., Benoit, L., Minassian, S., Mallet, J., & Moro, M. R. (2021). Clinical Lycanthropy, Neurobiology, Culture: A Systematic Review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.718101
253. Gupta, K., & Mamidi, P. (2020). Vataja Unmada: Schizophrenia or Dementia or Mood Disorder with Psychosis?. International Journal of Yoga - Philosophy Psychology and Parapsychology. https://doi.org/10.4103/ijny.ijoyppp_24_19
254. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
255. Guszkowska, M. (2013). [Exercise dependence--symptoms and mechanisms].. PubMed.
256. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
257. Gélinas, C., Klein, K., Naidech, A., & Skrobik, Y. (2013). Pain, Sedation, and Delirium Management in the Neurocritically Ill: Lessons Learned from Recent Research. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/s-0033-1342986
258. Haapanen, M. (2008). SPEEDY babies: A putative new behavioral syndrome of unbalanced motor-speech development. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s2640
259. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
260. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
261. Hales, R. E., & Yudofsky, S. C. (1996). Synopsis of psychiatry.
262. Hamdan, F. F., Holder, J. L., & Michaud, J. L. (2019). SYNGAP1-Related Intellectual Disability.
263. Hamdani, H., Mtalai, N., Ennaki, S., Daghouj, G., Maaloum, L. E., Allali, B., & Kettani, A. E. (2023). Congenital Insensitivity TO Pain: A Case Report. European Journal of Medical and Health Sciences. https://doi.org/10.24018/ejmed.2023.5.4.1782
264. Hammill, D. D., Leigh, J., McNutt, G., & Larsen, S. C. (1987). A New Definition of Learning Disabilities. Journal of Learning Disabilities. https://doi.org/10.1177/002221948702000207
265. Hassel, S., McKinnon, M. C., Cusi, A. M., & MacQueen, G. (2011). An Overview of Psychological and Neurobiological Mechanisms by which Early Negative Experiences Increase Risk of Mood Disorders.. PubMed.
266. Hayati, R. (2019). Terapi Gerak pada Anak Sindrom Desintegratif.
267. Heilbroner, P. L., & Castaneda, G. Y. (2007). Pediatric neurology : essentials for general practice. Lippincott Williams & Wilkins eBooks.
268. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
269. Hernández, J. V., Robledo, M. E. B., González, C. A. H., Escobar, C. S. M., Otalvaro, S. O., Tobón, J. D. S., Pava, P. M. A. D. L., & Criado‐Álvarez, J. J. (2021). Neuropsychiatric Aspects in a Patient Diagnosed with Frontotemporal Dementia: Clinical Case of Low Incidence and Prevalence Disease in Colombia. Case Reports in Neurology. https://doi.org/10.1159/000513851
270. Hildawati, H. (2021). PROBLEMATIKA GANGGUAN KECEMASAN PADA LANJUT USIA DI LINGKUNGAN SOSIAL. Moderasi Jurnal Studi Ilmu Pengetahuan Sosial. https://doi.org/10.24239/moderasi.vol2.iss2.41
271. Hirano, M. (2016). Mitochondrial Neurogastrointestinal Encephalopathy Disease.
272. Honig, L. S., Bell, K. L., & Chin, S. S. (2003). Frontotemporal Dementia. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2003.13.dn1
273. Horvat, M., Croce, R., & Fallaize, A. (2016). Information Processing and Motor Control in Down Syndrome. Journal of Down Syndrome & Chromosome Abnormalities. https://doi.org/10.4172/2472-1115.1000107
274. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/j.2040-4603.2014.tb00584.x
275. Housley, S. B., Patel, D., Nyabuto, E., & Reynolds, R. M. (2021). Spinal cord detethering without laminectomy or laminotomy. Surgical Neurology International. https://doi.org/10.25259/sni_942_2021
276. Howes, O., McDonald, C., Cannon, M., Arseneault, L., Boydell, J., & Murray, R. (2004). Pathways to schizophrenia: the impact of environmental factors. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145704004122
277. Hsieh, M. T., Peng, W., Wu, C., Ng, K., Cheng, C. Y., & Xu, H. (2010). None. Planta Medica. https://doi.org/10.1055/s-002-20741
278. Hu, L., Lin, Y., Chang, H., Lu, T., & Lin, W. (2015). Low‐dose Methylphenidate Monotherapy for Features of Attention‐Deficit/Hyperactivity Disorder Secondary to Hereditary Cerebellar Ataxia. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.12403
279. Huprich, S. K. (2010). Schizoid Personality Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0819
280. Hussain, E., Momin, A., Islam, M., Haque, S., Hossain, M. A., Chowdhury, R., & Hoque, A. (2016). Lafora Body Disease: A Rare Type of Progressive Myoclonic Epilepsy. American Journal of Medical Case Reports. https://doi.org/10.12691/ajmcr-4-3-2
281. Hyman, S. (2011). Asking the right questions. Neurology. https://doi.org/10.1212/wnl.0b013e3182377fbb
282. Häuser, W., Dinkel, A., & Lahmann, C. (2012). Funktionelle gastrointestinale Störungen. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-0032-1304958
283. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
284. Idiazábal-Aletxa, M. A., & Saperas-Rodríguez, M. (2008). [Auditory processing in specific language disorder].. PubMed.
285. Iida, M. (2000). A Study on Ryodoraku Pattern in Psychiatric Disoreders. The Japanese Journal of Ryodoraku Medicine. https://doi.org/10.17119/ryodoraku1986.45.246
286. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
287. Inmaculada, M., & Pérez, P. B. (2016). Neuronal and behavioural effects of social isolation in old age.
288. Iodice, A. (2019). Eating Epilepsy: Pathophysiologic Models, Electroclinical Phenotypes, and Outcome. Journal of Pediatric Epilepsy. https://doi.org/10.1055/s-0039-1697680
289. Isohanni, M., Lauronen, E., Moilanen, K., Isohanni, I., Kemppainen, L., Koponen, H., Miettunen, J., Mäki, P., Räsänen, S., Veijola, J., Tienari, P., Wahlberg, K., & Murray, G. K. (2005). Predictors of schizophrenia. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.187.48.s4
290. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
291. Jablensky, A. (2012). Course and outcome of schizophrenia and their prediction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0078
292. Jacobs, A., & Herzog, A. G. (1995). Psychiatric Classification of Nonconversion Nonepileptic Seizures. Archives of Neurology. https://doi.org/10.1001/archneur.1995.00540350030006
293. Jain, K. K. (2011). Introduction. Humana Press eBooks. https://doi.org/10.1007/978-1-61779-049-2_1
294. Jain, K. K. (2019). Introduction. Springer protocols handbooks/Springer protocols. https://doi.org/10.1007/978-1-4939-9465-6_1
295. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
296. Jakl, M., Skořepa, P., & Horáček, J. M. (2016). IMPACT OF EXTREME PHYSICAL EXERCISE ON HUMAN BODY. Military Medical Science Letters. https://doi.org/10.31482/mmsl.2016.026
297. Jan, M. M. (2012). Developmental Disorders. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805022211201010021
298. Jeon, S. W., & Kim, Y. K. (2016). Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?. World Journal of Psychiatry. https://doi.org/10.5498/wjp.v6.i3.283
299. Joyce, E. M. (2016). Neuropsychiatry. Neurology. https://doi.org/10.1002/9781118486160.ch22
300. Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Kloet, E. R. D., Fardet, L., Joëls, M., Leung, D. Y., McEwen, B. S., Roozendaal, B., Rossum, E. F. C. V., Ahn, J., Brown, D. W., Plitt, A., & Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091264
301. Jung, K. (2015). Cognition in Restless Legs Syndrome. Journal of Sleep Medicine. https://doi.org/10.13078/jsm.15001
302. Juraś-Darowny, M. (2022). Assessment of psychotic disorders among prelingually deaf individuals. Postępy Psychiatrii i Neurologii. https://doi.org/10.5114/ppn.2022.118131
303. Kahler, S. G., & Fahey, M. (2003). Metabolic disorders and mental retardation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.10018
304. Kaibuchi, K., & Tsuboi, D. (2010). Current perspective on the pathogenesis of schizophrenia from the viewpoint of risk factors such as DISC1 (corrected).
305. Kaiser, S., Heekeren, K., & Simon, J. J. (2011). The Negative Symptoms of Schizophrenia: Category or Continuum?. Psychopathology. https://doi.org/10.1159/000325912
306. Kamperidis, N., & Nightingale, J. M. D. (2022). Neurological disorders and small bowel dysmotility. Current Opinion in Gastroenterology. https://doi.org/10.1097/mog.0000000000000836
307. Kandolkar, A. C., & Kenchappanavar, R. N. (2014). Burden of Care and Parent-Child Relationship of Parents of Autistic Children. JOURNAL OF PSYCHOSOCIAL RESEARCH.
308. Kapczinski, F. (2015). Biomarkers of Neuroprogression in Bipolar Disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31830-7
309. Karyakina, M., & Rychkova, O. (2021). Cognitive impairments in schizophrenia in foreign studies: single function deficits or group of syndromes?. Journal of Modern Foreign Psychology. https://doi.org/10.17759/jmfp.2021100201
310. Katiri, R., Hall, D. A., & Kitterick, P. T. (2020). Developing an International Core Outcome Set for SSD Interventions. The Hearing Journal. https://doi.org/10.1097/01.hj.0000661612.83232.57
311. Kavan, M., Elsasser, G. N., & Barone, E. J. (2012). The physician's role in managing acute stress disorder.. PubMed.
312. Kavanaugh, B. C., Dupont-Frechette, J. A., Jerskey, B. A., & Holler, K. (2016). Neurocognitive deficits in children and adolescents following maltreatment: Neurodevelopmental consequences and neuropsychological implications of traumatic stress. Applied Neuropsychology Child. https://doi.org/10.1080/21622965.2015.1079712
313. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
314. Kendall, T., Megnin‐Viggars, O., Gould, N., Taylor, C., Burt, L., & Baird, G. (2013). Management of autism in children and young people: summary of NICE and SCIE guidance. BMJ. https://doi.org/10.1136/bmj.f4865
315. Kenneth, M. H. (2004). Intentional neglect. Frontiers in bioscience. https://doi.org/10.2741/1261
316. Kerchner, G. A., & Rosenbloom, M. (2014). Frontotemporal Neurocognitive Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg65
317. Kesby, J. P., Murray, G. K., & Knolle, F. (2021). Neural Circuitry of Salience and Reward Processing in Psychosis. Biological Psychiatry Global Open Science. https://doi.org/10.1016/j.bpsgos.2021.12.003
318. Khan, I., & Khan, M. A. (2021). Sensory and Perceptual Alterations. StatPearls.
319. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
320. Kim, S. M. (2000). The Strategy of Clinical Procedure for Determining Brain Death. Korean Journal of Medical Ethics. https://doi.org/10.35301/ksme.2000.3.1.1
321. Kirkpatrick, B. (2014). Recognizing Primary Vs Secondary Negative Symptoms and Apathy Vs Expression Domains. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.13049tx3c
322. Klein, S. (2015). Autistic phenomena in neurotic patients 1. Routledge eBooks. https://doi.org/10.4324/9781315743882-10
323. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
324. Knipper, M., Singer, W., Schwabe, K., Hagberg, G., Hegner, Y. L., Rüttiger, L., Braun, C., & Land, R. (2022). Disturbed Balance of Inhibitory Signaling Links Hearing Loss and Cognition. Frontiers in Neural Circuits. https://doi.org/10.3389/fncir.2021.785603
325. Knupp, K. G., & Wirrell, E. (2014). Progressive myoclonic epilepsies. Neurology. https://doi.org/10.1212/wnl.0000000000000091
326. Koffel, E., & Watson, D. (2010). Unusual sleep experiences, dissociation, and schizotypy. https://doi.org/10.17077/15jq-9y57
327. Koga, M. (2013). Another CNS phenotype of anti-GQ1b antibody syndrome. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-305236
328. Koike, H., & Sobue, G. (2013). [Sjogren's syndrome-associated neuropathy].. PubMed.
329. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
330. Korn‐Lubetzki, I., Steiner‐Birmanns, B., Galperin, I., Benasouli, Y., & Steiner, I. (2007). NONCONVULSIVE STATUS EPILEPTICUS IN OLDER PEOPLE: A DIAGNOSTIC CHALLENGE AND A TREATABLE CONDITION. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2007.01284.x
331. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
332. Krudop, W. A., Gossink, F., Vijverberg, E. G., Kerssens, C. J., Prins, N. D., Schouws, S., Dols, A., & Pijnenburg, Y. A. (2021). Diagnostiek van frontotemporale dementie in de psychiatrische praktijk: handvatten en valkuilen.
333. Krägeloh‐Mann, I. (2010). Clinical outcome: neurological sequelae following preterm birth. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511712166.004
334. Kuiper, J. S. (2016). The importance of social relationships in the process of cognitive ageing.
335. Kukla, U., Łabuzek, K., Chronowska, J., Krzystanek, M., & Okopień, B. (2015). [Mental disorders in digestive system diseases - internist's and psychiatrist's insight].. PubMed.
336. Kumar, S., & Flemming, K. D. (2021). Syndromes of Cognitive Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0076
337. Kumar, S., Rao, S. L., Sunny, B., & Gangadhar, B. N. (2007). Widespread cognitive impairment in psychogenic anterograde amnesia. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2007.01735.x
338. Lacassie, Y., Bobadilla, O., & Cambias, R. D. (1997). A boy with a mild case of Cornelia de Lange syndrome with above average intelligence. Journal of Intellectual & Developmental Disability. https://doi.org/10.1080/13668259700033511
339. Larner, A. J. (2012). Neurological Signs of Ageing. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119952930.ch53
340. Lassal, R., Laurent, M., & Purper‐Ouakil, D. (2011). [Early signs of mental disorders in children aged 3-12 years].. PubMed.
341. Latronico, N., Antonini, L., Taricco, M., Vignolo, L., & Candiani, A. (2000). [Approach to the patient in vegetative state. Part II: differential diagnosis].. PubMed.
342. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
343. Lavoie, S., Polari, A., Goldstone, S., Nelson, B., & McGorry, P. D. (2019). Staging model in psychiatry: Review of the evolution of electroencephalography abnormalities in major psychiatric disorders. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12792
344. Law, J. (2000). Treating children with speech and language impairments. BMJ. https://doi.org/10.1136/bmj.321.7266.908
345. Leersnyder, H. D. (2003). beta1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome. Journal of Medical Genetics. https://doi.org/10.1136/jmg.40.1.74
346. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
347. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
348. Leptourgos, P., & Corlett, P. R. (2020). Embodied Predictions, Agency, and Psychosis. Frontiers in Big Data. https://doi.org/10.3389/fdata.2020.00027
349. Leung, A. K. C., & Kao, C. P. (1999). Evaluation and management of the child with speech delay.. PubMed.
350. Leung, M., Thompson, B., Black, J., Dai, S., & Alsweiler, J. M. (2017). The effects of preterm birth on visual development. Clinical and Experimental Optometry. https://doi.org/10.1111/cxo.12578
351. Levenson, R. W., Sturm, V. E., & Haase, C. M. (2014). Emotional and Behavioral Symptoms in Neurodegenerative Disease: A Model for Studying the Neural Bases of Psychopathology. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev-clinpsy-032813-153653
352. Levy, J. A., & Chelune, G. J. (2007). Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988707308806
353. Lin, A., Wood, S. J., & Yung, A. R. (2013). Measuring psychosocial outcome is good. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e32835d82aa
354. Lin, L., Ferraz‐de‐Souza, B., & Achermann, J. C. (2007). Genetic Disorders Involving Adrenal Development. KARGER eBooks. https://doi.org/10.1159/000111056
355. Liu, Y., Zhao, J., Fan, X., & Guo, W. (2019). Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2019.00286
356. Liétor, M. M., Giancola, A. S., Iñiguez, I. C., García, C. Á., & Prieto, M. (2022). Hysteria in neurology: a diagnostic approach to conversive disorder. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1000
357. Lišková, P., Ulmanová, O., Těšina, P., Melsova, H., Diblík, P., Hansíková, H., Tesařová, M., & Votruba, M. (2013). Novel <i>OPA1</i> missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmologica. https://doi.org/10.1111/aos.12038
358. Lj, T. (1988). Dementia update: diagnosis and neuropsychiatric aspects.. PubMed.
359. Lockhart, S., Sawa, A., & Niwa, M. (2018). Developmental trajectories of brain maturation and behavior: Relevance to major mental illnesses. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2018.04.008
360. Loetscher, T. (2006). Misoplegia: a review of the literature and a case without hemiplegia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.087163
361. Lukačević, M. (2016). Depresivnost djece u primarnom obrazovanju.
362. Luna-Matos, M., Mcgrath, H., & Gaviria, M. (2007). Manifestaciones neuropsiquiátricas en accidentes cerebrovasculares Neuropsychiatric manifestations in cerebrovascular diseases.
363. Lunardi, S., Forlì, F., Michelucci, A., Liumbruno, A., Baldinotti, F., Fogli, A., Bertini, V., Valetto, A., Toschi, B., Simi, P., Boldrini, A., Berrettini, S., & Ghirri, P. (2012). Genetic Hearing Loss Associated with Craniofacial Abnormalities. InTech eBooks. https://doi.org/10.5772/32622
364. López, O. L., García‐Portilla, M. P., Becker, J. T., Reynolds, C. F., Sudilovsky, A., & DeKosky, S. T. (1995). Symptoms of Depression in Alzheimer's Disease, Frontal Lobe‐type Dementia, and Subcortical Dementia. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1995.tb38153.x
365. Löfgren, S., Verdier, K. D., Ek, U., & Fernell, E. (2016). Early childhood blindness – etiologies and comorbidity. Acta Ophthalmologica. https://doi.org/10.1111/j.1755-3768.2016.0700
366. M.E., B., VergelHernández, J., C.A., H., C.S., M., Ospina-Otálvaro, S., J.D., S., P.M., A., J.J., A., Basic, A. C. N. S. R. T. O., & Psychiatry, S. O. M. R. T. O. (2021). Supplementary Material for: Neuropsychiatric Aspects in a Patient Diagnosed with Frontotemporal Dementia: Clinical Case of Low Incidence and Prevalence Disease in Colombia. Figshare. https://doi.org/10.6084/m9.figshare.14932008
367. Maddocks, I., Brew, B. J., Waddy, H., & Williams, I. (2005). Cognitive, behavioural and psychological symptoms. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.015
368. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
369. Maeda, H. (1993). A Tentative Classification of “Neuroses” Based on Behavioristic Consideration of the Pathogenetic Mechanisms. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.1993.tb01823.x
370. Mahapatra, A., Sood, M., Bhad, R., & Tripathi, M. (2016). Behavioural Variant Frontotemporal Dementia with Bilateral Insular Hypometabolism: A Case Report. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2016/16536.7638
371. Mahesh, R., Pandey, D. K., Bhatt, S., & Gautam, B. (2010). Depression Associated Disorders: Comorbidity, eurobiological and eurobehavioural Link.
372. Mahon, S. M., & Carr, E. (2021). Cognitive Dysfunction: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.23
373. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
374. Malaty, J., & Malaty, I. A. (2013). Smell and taste disorders in primary care.. PubMed.
375. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
376. Malin, H., & Saleh, F. M. (2007). Paraphilias: Clinical and Forensic Considerations.
377. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
378. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
379. Manso-Calderón, R., & Sevillano-García, M. D. (2010). [Nonmotor symptoms in Parkinson's disease and deep brain stimulation].. Revista de Neurología.
380. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
381. Maria, B. L., Boltshauser, E., Palmer, S. C., & Tran, T. X. (1999). Clinical Features and Revised Diagnostic Criteria in Joubert Syndrome. Journal of Child Neurology. https://doi.org/10.1177/088307389901400906
382. Marra, C. M. (1996). Peripheral Neuropathy. https://doi.org/10.1093/oso/9780195100365.003.0057
383. Martens, W. H. J., & Kahn, W. A. (2003). Emotional Capacities and Sensitivity in Psychopaths.
384. Martin, P., Rautenstrauβ, B., Abicht, A., Fahrbach, J., & Köster, S. (2010). Severe Myoclonic Epilepsy in Infancy – Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases. Molecular Syndromology. https://doi.org/10.1159/000326746
385. Martins, E., Durães, J., Nogueira, C., Gomes, J. A., Vilarinho, L., & Macário, C. (2023). SERAC1 Deficiency- A New Phenotype. Endocrine Metabolic & Immune Disorders - Drug Targets. https://doi.org/10.2174/1871530323666230914114456
386. Martone, G. (2019). The inflammation hypothesis and mental illness.
387. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
388. Maruta, C., Marôco, J., Mendonça, A. D., & Guerreiro, M. (2016). Behavior Symptoms in Primary Progressive Aphasia Variants. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_3
389. Masgutova, S., Wenberg, S., & Retschler, M. (2008). MASGUTOVA METHOD OF REFLEX INTEGRATION FOR CHILDREN WITH CEREBRAL PALSY.
390. Mastronardi, V., Vita, L. D., & Ronchi, F. U. (2012). [Some Italian research on the phenomenon of filicide].. PubMed. https://doi.org/10.1708/1140.12565
391. Mayer, E. A., Naliboff, B. D., & Chang, L. (2001). Basic Pathophysiologic Mechanisms in Irritable Bowel Syndrome. Digestive Diseases. https://doi.org/10.1159/000050682
392. Mayer, G. (2008). Excessive somnolence disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545085.007
393. Mayo‐Wilson, E., Montgomery, P., & Dennis, J. A. (2007). PROTOCOL: Personal assistance for children and adolescents (0‐18) with both physical and intellectual impairments. Campbell Systematic Reviews. https://doi.org/10.1002/cl2.41
394. Mayo‐Wilson, E., Montgomery, P., & Dennis, J. A. (2007). PROTOCOL: Personal assistance for children and adolescents (0‐18) with intellectual impairments. Campbell Systematic Reviews. https://doi.org/10.1002/cl2.37
395. McCarthy, R. A., & Warrington, E. K. (1990). Speech Production. Cognitive Neuropsychology. https://doi.org/10.1016/b978-0-12-481845-3.50012-6
396. McFadden, K. M. (2010). Cross-Addiction: From Morbid Obesity to Substance Abuse. Bariatric Nursing and Surgical Patient Care. https://doi.org/10.1089/bar.2010.9922
397. McLeod, T. C. V., & Register‐Mihalik, J. K. (2011). Clinical Outcomes Assessment for the Management of Sport-Related Concussion. Journal of Sport Rehabilitation. https://doi.org/10.1123/jsr.20.1.46
398. McNaughton, N., & Corr, P. J. (2016). Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders. Development and Psychopathology. https://doi.org/10.1017/s0954579416000699
399. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
400. Medjkane, F., Bohet, M., Ister, M., Cohen, D., Parenti, A., Janati, M., Mention, K., Dobbelaere, D., & Jardri, R. (2021). Onset of psychiatric signs and impaired neurocognitive domains in inherited metabolic disorders: A case series. JIMD Reports. https://doi.org/10.1002/jmd2.12133
401. Meeusen, R., Duclos, M., Foster, C., Fry, A. C., Gleeson, M., Nieman, D. C., Raglin, J. S., Rietjens, G., Steinacker, J. M., & Urhausen, A. (2013). Prevention, Diagnosis, and Treatment of the Overtraining Syndrome. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e318279a10a
402. Mehta, U. M., Kumar, C. N., Venkatasubramanian, G., & Thirthalli, J. (2013). Multimodal Sensory Distortions in Postpartum Exacerbation of Schizophrenia. Clinical Schizophrenia & Related Psychoses. https://doi.org/10.3371/csrp.meku.112013
403. Meijer, I. A. (2019). VPS13D Movement Disorder.
404. Meißner, C., Oehmichen, M., & Saternus, K. (2005). Fall or Shaken: Traumatic Brain Injury in Children Caused by Falls or Abuse at Home - A Review on Biomechanics and Diagnosis. Neuropediatrics. https://doi.org/10.1055/s-2005-872812
405. Melo, C., & Temudo, T. (2015). Stereotypies: From Normal to Pathological. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0035-1559805
406. Mendez, M. F. (2022). A Functional and Neuroanatomical Model of Dehumanization. Cognitive and Behavioral Neurology. https://doi.org/10.1097/wnn.0000000000000316
407. Mendez, M. F., Lauterbach, E. C., & Sampson, S. (2008). An Evidence-Based Review of the Psychopathology of Frontotemporal Dementia: A Report of the ANPA Committee on Research. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.2008.20.2.130
408. Mendez, M. F., Shapira, J. S., & Saul, R. E. (2011). The Spectrum of Sociopathy in Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.23.2.132
409. Mendez, M. F., Shapira, J., & Saul, R. E. (2011). The Spectrum of Sociopathy in Dementia. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.23.2.jnp132
410. Menecier, P., Rouaud, O., Arezes, C., Nasr, D., Menecier-Ossia, L., Charvet-Blanc, A., & Ploton, L. (2007). [Bipolar disorders and dementia: fortuitous association or filiation? A case-report and review of the literature]. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2007.0035
411. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
412. Mesulam, M. (2013). Primary progressive aphasia: A dementia of the language network. Dementia & Neuropsychologia. https://doi.org/10.1590/s1980-57642013dn70100002
413. Mesulam, M. (2016). Primary Progressive Aphasia and the Left Hemisphere Language Network. Dementia and Neurocognitive Disorders. https://doi.org/10.12779/dnd.2016.15.4.93
414. Mihaljević-Peleš, A., Janović, M. B., Šagud, M., Živković, M., Janović, Š., & Jevtović, S. (2019). Cognitive deficit in schizophrenia: an overview.. PubMed.
415. Miki, T., Yokota, O., Ishizu, H., Kuroda, S., Oshima, E., Terada, S., & Yamada, N. (2016). Behavioral variant of frontotemporal dementia: Fundamental clinical issues associated with prediction of pathological bases. Neuropathology. https://doi.org/10.1111/neup.12290
416. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
417. Milloy, N. R. (2014). Breakdown of Speech: Causes and remediation.
418. Minton, C. A. B., Bruner, S. M., & Morris, C. A. W. (2017). Diagnosis and Treatment of Children and Adolescents. Routledge eBooks. https://doi.org/10.4324/9781315466736-15
419. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
420. Mitchell, P. B., Goodwin, G. M., Johnson, G. F., & Hirschfeld, R. M. A. (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00559.x
421. Mitsuyama, Y. (1984). Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.47.9.953
422. Mitsuyama, Y. (2000). Dementia with motor neuron disease. Neuropathology. https://doi.org/10.1046/j.1440-1789.2000.00302.x
423. Mohorović, T. (2015). Shizofrenija u dječjoj i adolescentnoj dobi.
424. Mondimore, F. M., & Kelly, P. (2011). Borderline Personality Disorder: New Reasons for Hope.
425. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
426. Moretti, R., Torre, P., Antonello, R. M., Cattaruzza, T., & Cazzato, G. (2005). Difficulties in the Management of Frontal Dementia: Therapeutics Strategies. Letters in Drug Design & Discovery. https://doi.org/10.2174/1570180053765147
427. Morgan, A., Fisher, S. E., Scheffer, I. E., & Hildebrand, M. S. (2016). FOXP2-Related Speech and Language Disorders. University of Washington, Seattle eBooks.
428. Moshé, S. L., Tuchman, R. F., & Rapin, I. (2005). [Neurodevelopmental disorders and epilepsy].. PubMed.
429. Mott, J., & Morrison, J. A. (2019). Hypertension, Portal. Blackwell's Five‐Minute Veterinary Consult Clinical Companion. https://doi.org/10.1002/9781119376293.ch130
430. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
431. Moyo⃰, G. P. K. (2020). Perinatality and Childbirth as a Factor of Decompensation of Mental Illness: The Case of Depressive States in Newly Delivered Cameroonian Women. Archives in Biomedical Engineering & Biotechnology. https://doi.org/10.33552/abeb.2020.04.000592
432. Mucci, A., & Galderisi, S. (2017). Cognitive Dysfunctions in the Psychoses and their Impact on Patients’ Social Functioning. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.205
433. Mucci, A., & Galderisi, S. (2017). The Evolution of Negative Symptom Constructs. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.096
434. Mucci, A., Bucci, P., Giordano, G. M., Brando, F., & Galderisi, S. (2021). Apathy in schizophrenia: assessment in clinical settings and overlap with other dimensions of impairment. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.159
435. Mullé, J. G., Gambello, M. J., Cook, E. H., Rutkowski, T. P., & Glassford, M. R. (1993). 3q29 Recurrent Deletion. University of Washington, Seattle eBooks.
436. Mulroy, E., Baschieri, F., Magrinelli, F., Latorre, A., Cortelli, P., & Bhatia, K. P. (2021). Movement Disorders and Liver Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13238
437. Murphy, D. L., Timpano, K. R., Wheaton, M. G., Greenberg, B. D., & Miguel, E. C. (2010). Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2010.12.2/dmurphy
438. Murray, R. B. (1996). Stressors and Coping Strategies of Homeless Men. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19960801-13
439. Musazzi, L., & Marrocco, J. (2016). The Many Faces of Stress: Implications for Neuropsychiatric Disorders. Neural Plasticity. https://doi.org/10.1155/2016/8389737
440. Muskin, P. R. (2014). DSM-5 Self-Exam Questions: Test Questions for the Diagnostic Criteria.
441. Musálek, M. (2011). Pathologisches Spielen: Impulskontrollstörung oder Sucht?. Suchttherapie. https://doi.org/10.1055/s-0031-1284655
442. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
443. Myers, K. A., & Scheffer, I. E. (2016). GRIN2A-Related Speech Disorders and Epilepsy. University of Washington, Seattle eBooks.
444. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
445. Nabi, S. U., Dey, S., Gupta, G., Kumar, A., Vala, J., & Jan, M. H. (2010). A study of neuromuscular dysfunctions in geriatric dogs.. Haryana Veterinarian.
446. Nadeem, M. S., Murtaza, B. N., Al-Ghamdi, M. A., Ali, A., Zamzami, M. A., Khan, J. A., Ahmad, A., Rehman, M. U., & Kazmi, I. (2021). Autism - A Comprehensive Array of Prominent Signs and Symptoms. Current Pharmaceutical Design. https://doi.org/10.2174/1381612827666210120095829
447. Naidu, S., Bibat, G., Lin, D., Burger, P. C., Barker, P. B., Rosemberg, S., Braverman, N., Arroyo, H., Dowling, M. M., Hamosh, A., Kimonis, V., Blank, C., Fiumara, A., Facchini, S., Singhal, B., Moser, H. W., Kelley, R. I., & DiMauro, S. (2005). Progressive cavitating leukoencephalopathy: A novel childhood disease. Annals of Neurology. https://doi.org/10.1002/ana.20671
448. Nambu, A. (2012). Pathophysiology of movement disorders. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.52.1198
449. Narayan, S. K., Sivaprasad, P., Sahoo, R. N., & Bhuvaneswari, V. (2008). Teaching Video Neuro <i>Image</i> : Chvostek sign with Fahr syndrome in a patient with hypoparathyroidism. Neurology. https://doi.org/10.1212/01.wnl.0000336974.93499.ad
450. Narayanan, D. L., Kutsche, K., & Girisha, K. M. (2021). EBF3 Neurodevelopmental Disorder.
451. Nardi, A. E., & Hoirisch-Clapauch, S. (2013). Multiple Roles of Tissue Plasminogen Activator in Schizophrenia Pathophysiology. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0033-1357505
452. Narvid, J., & Gorno‐Tempini, M. L. (2008). Frontotemporal lobar degeneration. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198569275.003.0013
453. Nelson, B., & Sass, L. A. (2018). 28.1 VARIETIES OF SELF DISORDER: A BIO-PHENO-SOCIAL MODEL OF SCHIZOPHRENIA. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sby014.116
454. Nesteruk, M., Nesteruk, T., Ułamek-Kozioł, M., Holak-Puczyńska, A., & Dorobek, M. (2019). Creutzfeldt-Jakob disease mimicking Lewy body dementia – a case report. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/110915
455. Nizamie, A., Sengupta, U., Mishra, B. R., Praharaj, S. K., & Nizamie, S. H. (2010). Alka Nizamie;Uma Sengupta;Biswa Ranjan Mishra;Samir Kumar Praharaj;S. Haque Nizamie. Acta Neurologica Taiwanica. https://doi.org/10.29819/ant.201003.0008
456. Nizamie, A., Sengupta, U., Mishra, B. R., Praharaj, S. K., & Nizamie, S. H. (2010). Role of early multimodal interventions in a case with autistic regression.. PubMed.
457. Noble, J. M. (2022). Frontotemporal Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0008
458. Notermans, N. C., & Doorn, P. A. V. (1997). [Polyneuropathy: diagnosis and management].. PubMed.
459. Novotný, J., & Křeménková, L. (2007). Změny kognitivních emočních, motorických a sociálních procesů ujedinců s FASD.
460. Oliveros‐Cid, A., Lorente, V. C., Oliveros‐Juste, A., Cimorra, B. D., Luque, L. C., Lopez, M. A. C., Martinez, E. S., Moreno, L. R., & Izaguerri, C. (2023). Neuropsychological Profile of Internal Frontal Hyperostosis. Alzheimer s & Dementia. https://doi.org/10.1002/alz.077384
461. Olson, D. M., Westermarck, T., & Ekvall, S. W. (2005). Seizures And Epilepsy. https://doi.org/10.1093/oso/9780195165647.003.0010
462. Olszewski, J., Zielińska‐Bliźniewska, H., & Pietkiewicz, P. (2011). Zaburzenia połykania jako interdyscyplinarny problem diagnostyczny i leczniczy. Polski Przegląd Otorynolaryngologiczny. https://doi.org/10.1016/s2084-5308(11)70060-0
463. Ospina, B., & Vélez, J. L. O. (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
464. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
465. Otsuki, M. (2012). Cognitive impairment implicated in the damage to the frontal lobe and the basal ganglia. Higher Brain Function Research. https://doi.org/10.2496/hbfr.32.194
466. Otsuki, M. (2015). Symptoms and prognosis of PNFA / nfvPPA. Higher Brain Function Research. https://doi.org/10.2496/hbfr.35.297
467. O’Connor, F. G., & Levine, B. D. (2015). Syncope in Athletes of Cardiac Origin. Current Sports Medicine Reports. https://doi.org/10.1097/01.csmr.0000465136.70746.5b
468. O’Donnell, B. F. (2007). Cognitive Impairment in Schizophrenia: A Life Span Perspective. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317507304745
469. O’Hare, A. (2015). Management of developmental speech and language disorders. Part 2: acquired conditions. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2014-306153
470. Pailhez, G., Castaño, J. G., Rosado, S., Ballester, M. D. M., Vendrell, C., Mallorquí‐Bagué, N., Baeza‐Velasco, C., & Bulbena, A. (2015). Joint Hypermobility, Anxiety, and Psychosomatics — The New Neuroconnective Phenotype. InTech eBooks. https://doi.org/10.5772/60607
471. Palla, M. R., Khan, G., Haghighat, Z., & Bada, H. S. (2019). EEG Findings in Infants With Neonatal Abstinence Syndrome Presenting With Clinical Seizures. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2019.00111
472. Pallesen, S., Olsen, O. K., Eide, E. M., Nortvedt, B., Grønli, J., Larøi, F., Nordmo, M., & Glomlien, F. E. (2018). Sleep deprivation and hallucinations. A qualitative study of military personnel. Military Psychology. https://doi.org/10.1080/08995605.2018.1478561
473. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
474. Pan, Z., Grovu, R. C., Danielle, S., Carmona, N. E., Subramaniapillai, M., Shekotikhina, M., Rong, C., Lee, Y., & McIntyre, R. S. (2018). Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527316666170919115100
475. Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2018). Cognitive impairment in major depressive disorder. CNS Spectrums. https://doi.org/10.1017/s1092852918001207
476. Pandit, M. S., Gupta, A., Mathur, P., Sharma, M., & Garg, M. (2016). JOURNAL OF PEDIATRIC CRITICAL CARE. JOURNAL OF PEDIATRIC CRITICAL CARE. https://doi.org/10.21304/2016.0302.00123
477. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
478. Park, E. S. (2009). 뇌성마비 아동의 씹기 능력 관련 요인.
479. Park, E. S. (2009). 뇌성마비 아동의 씹기 능력 관련 요인. Eon'eo cheong'gag jang'ae yeon'gu/Communication sciences & disorders.
480. Pascual‐Leone, Á., Ramachandran, V. S., Cole, J., Sala, S. D., Manly, T., Mayes, A. R., & Sacks, O. (2011). The Paradoxical Brain. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511978098
481. Pasricha, S. (2011). Relevance of para-psychology in psychiatric practice. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.75544
482. Passantino, A., & Masucci, M. (2016). Congenital and inherited neurologic diseases in dogs and cats: Legislation and its effect on purchase in Italy. Veterinary World. https://doi.org/10.14202/vetworld.2016.437-443
483. Patel, D. R., & Merrick, J. (2020). Neurodevelopmental and neurobehavioral disorders. Translational Pediatrics. https://doi.org/10.21037/tp.2020.02.03
484. Patel, S., Vyas, N., Patel, A., Shah, U., Raval, M., Patel, M., & Patel, A. (2022). Comprehensive Review of Ethnopharmacological and Phytochemical Aspects of Nutraceuticals in Psychiatric Disorders. Current Psychopharmacologye. https://doi.org/10.2174/2211556011666220510141329
485. Patti, L., & Gupta, M. (2019). Change In Mental Status. StatPearls.
486. Penn, M., & Goldstein, D. (2005). The Role of Hunger and Satiety in Weight Management. Humana Press eBooks. https://doi.org/10.1385/1-59259-865-x:307
487. Pereira, S. M. P., Guimarães, S. K. G., Marques, A., & Borges, S. (2008). Electroconvulsivotherapy in the elderly, indications, risks and side-effects. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.611
488. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
489. Peron, A., Bradbury, K., Viskochil, D., & Dias, C. (2019). BCL11A-Related Intellectual Disability.
490. Petrazzuoli, F., Lionis, C., & Young, V. (2019). Managing patients with dementia. Routledge eBooks. https://doi.org/10.4324/9780429026386-9
491. Peven, J. C., Stillman, C. M., & Erickson, K. I. (2019). The Influence of Physical Exercise on Cognitive Aging. Cambridge University Press eBooks. https://doi.org/10.1017/9781108554350.016
492. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
493. Phu, T., Remmers, A., Schytz, H. W., Schankin, C. J., Nelson, S. E., Obermann, M., Hansen, J. M., Sinclair, A. J., Gantenbein, A. R., & Schoonman, G. (2018). Red and orange flags for secondary headaches in clinical practice. Neurology. https://doi.org/10.1212/wnl.0000000000006697
494. Piagkou, M., Demesticha, T., Piagkos, G., Georgios, A., & Panagiotis, S. (2010). Lingual Nerve Entrapment in Muscular and Osseous Structures. International Journal of Oral Science. https://doi.org/10.4248/ijos10063
495. Pincherle, A., Rossi, F., Jöhr, J., Dunet, V., Ryvlin, P., Oddo, M., Schiff, N., & Diserens, K. (2020). Early discrimination of cognitive motor dissociation from disorders of consciousness: pitfalls and clues. Journal of Neurology. https://doi.org/10.1007/s00415-020-10125-w
496. Pivac, N., Perković, M. N., Erjavec, G. N., Dodig‐Ćurković, K., Ćurković, M., Škledar, M., & Mück‐Šeler, D. (2010). Molecular markers of behavioral and emotional disorders.
497. Poletti, M., & Bonuccelli, U. (2011). From Narcissistic Personality Disorder to Frontotemporal Dementia: A Case Report. Behavioural Neurology. https://doi.org/10.1155/2011/328962
498. Poletti, M., Preti, A., & Raballo, A. (2022). Eating Disorders and Psychosis as Intertwined Dimensions of Disembodiment: A Narrative Review.. PubMed. https://doi.org/10.36131/cnfioritieditore20220307
499. Poornima, S. (2018). Psychology Case Record.
500. Popkirov, S., Asadi‐Pooya, A. A., Duncan, R., Gigineishvili, D., Hingray, C., Kanner, A. M., LaFrance, W. C., Pretorius, C., & Reuber, M. (2019). The aetiology of psychogenic non‐epileptic seizures: risk factors and comorbidities. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1107
501. Posner, J. B., Saper, C. B., Schiff, N. D., & Plum, F. (2008). Structural Causes of Stupor and Coma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195321319.003.0145
502. Post, R. M. (2016). Mechanisms of Sensitization to Stress, Affective Episodes, and Abused Substances. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199367894.003.0013
503. Postma, A., Nelson, C. M., Dijk, J. V., & Dijk, R. V. (2010). Deaf Children with Severe Multiple Disabilities:. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195390032.013.0012
504. Potvin, O., Hudon, C., Grenier, S., & Préville, M. (2010). Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia. International Psychogeriatrics. https://doi.org/10.1017/s1041610210001419
505. Potvin, S., Stavro, K., & Pelletier, J. (2012). Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors. Journal of Dual Diagnosis. https://doi.org/10.1080/15504263.2012.648549
506. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
507. Prasse, J. E., & Kikano, G. E. (2008). Stuttering: an overview.. PubMed.
508. Pratibha, S. (2010). Etiology of Late Onset Seizures.
509. Presečki, P., Filipčić, I., Arbanas, G., & Mimica, N. (2014). Neurocognitive disorders in DSM-5.
510. Prvčić, I., Zec, M. R., & Barišić, I. (2008). Psychological aspects of learning disabilities. Paediatria Croatica. https://doi.org/10.13112/pc.925
511. Pugliese, M., Rossi, C., Guidotti, I., Gallo, C., Casa, E. D., Bertoncelli, N., Coccolini, E., & Ferrari, F. (2013). Preterm birth and developmental problems in infancy and preschool age Part II: cognitive, neuropsychological and behavioural outcomes. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.3109/14767058.2013.794205
512. Putri, P. R. N. E. (2020). Asuhan keperawatan diabetes mellitus tipe 2 dengan ulkus diabetik pada ny. J di upt puskesmas rawat inap sungai pakning.
513. Pérez, M. E. S., & Bajo-Santos, C. (2011). Alteraciones del lenguaje en pacientes afectos de síndrome de down. Otorrinolaringológica de Castilla y León, Cantabria y La Rioja.
514. Quadri, M. (2013). Finding Genes for Parkinsonism.
515. Rader, R. K., McCauley, L., & Callen, E. C. (2009). Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.. PubMed.
516. Rajakulendran, S., Pitceathly, R. D. S., Warren, J., Woodward, C., Sweeney, M. G., Hargreaves, I., Fratter, C., Heales, S., Taylor, R. W., Holton, J., Rahman, S. A., & Hanna, M. G. (2010). POG04 Multiple mitochondrial DNA deletions, cyclooxygenase-negative fibres and slowly progressive cognitive decline with psychiatric features. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.226340.126
517. Rajaprakash, M., & Leppert, M. (2022). Attention-Deficit/Hyperactivity Disorder. Pediatrics in Review. https://doi.org/10.1542/pir.2020-000612
518. Ramey, T., & Regier, P. S. (2018). Cognitive impairment in substance use disorders. CNS Spectrums. https://doi.org/10.1017/s1092852918001426
519. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
520. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
521. Rapkin, A. J., & Mikacich, J. (2007). Clinical evaluation and management. CRC Press eBooks. https://doi.org/10.3109/9781435628168-19
522. Ratai, E., Caruso, P. A., & Eichler, F. (2012). Advances in MR Imaging of Leukodystrophies. InTech eBooks. https://doi.org/10.5772/25151
523. Reed, U. C., Marie, S. K. N., Vainzof, M., Gobbo, L. F., Gurgel, J., Carvalho, M. S., Resende, M. B. D. D., Espíndola, A. Á. D., Zatz, M., & Diament, A. J. (2000). Heterogeneity of Classic Congenital Muscular Dystrophy With Involvement of the Central Nervous System: Report of Five Atypical Cases. Journal of Child Neurology. https://doi.org/10.1177/088307380001500306
524. Rees, S., Harding, R., & Walker, D. W. (2011). The biological basis of injury and neuroprotection in the fetal and neonatal brain. International Journal of Developmental Neuroscience. https://doi.org/10.1016/j.ijdevneu.2011.04.004
525. Reich, L. A., Kutzbach, T., Wilken, B., Hagen, M. V. D., Mückschel, M., & Beste, C. (2016). Assessing Cognition, Executive Functions, and Functional Brain Asymmetry in Children with Rett Syndrome. Neuropediatrics. https://doi.org/10.1055/s-0036-1583691
526. Reid, W. H., Balis, G. U., & Sutton, B. (1997). The treatment of psychiatric disorders : revised for DSM-IV.
527. Reijnders, M. R., Leventer, R. J., Lee, B. H., Baralle, D., Selber, P., Paciorkowski, A. R., & Hunt, D. (2017). PURA-Related Neurodevelopmental Disorders. University of Washington, Seattle eBooks.
528. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
529. Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019). Long-term Cognitive and Functional Impairments After Critical Illness. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004066
530. Reula, L. M., García, H. S., & Fernández, A. P. (2017). Relationship Between Early Maladaptive Schemes and Traumatic Childhood Experiences with Suicidal Behavior in Adults. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.2199
531. Richards, M. (2019). Physical frailty and decline in general and specific cognitive abilities. Journal of Epidemiology & Community Health. https://doi.org/10.1136/jech-2019-213410
532. Riederer, P., Hartmann, J., & Künig, G. (1993). Involvement of transmitter systems in neuropsychiatric diseases. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1993.tb00015.x
533. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
534. Rivas-Vazquez, R. A., Carrazana, E., Rey, G., & Wheeler, S. D. (2000). SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME: THREE CASES PRESENTING TO A NEUROLOGIC PRACTICE. The Neurologist. https://doi.org/10.1097/00127893-200006060-00005
535. Robertson, O. D., Coronado, N. G., Sethi, R., Berk, M., & Dodd, S. (2019). Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12775
536. Robinson (2000). Review article: recognition and treatment of eating disorders in primary and secondary care. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2000.00725.x
537. Robinson‐Papp, J. (2016). Autonomic Disorders. https://doi.org/10.1002/9781118621042.ch31
538. Romero, J. M. B. (2004). Un estudio clínico sobre la hipótesis secuencial de la clasificación endogena-neurótica de la depresión.
539. Rovai, D., Giannessi, D., Andreassi, M. G., Gentili, C., Pingitore, A., Glauber, M., & Gemignani, A. (2014). Mind injuries after cardiac surgery. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0000000000000133
540. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
541. Rozzini, L., Chilovi, B. V., Conti, M. Z., Delrio, I., Borroni, B., Trabucchi, M., & Padovani, A. (2007). Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000111133
542. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
543. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
544. Ružić, M. (2016). Poremećaj glasa kod osoba treće životne dobi.
545. Sadek, J., Pergam, S. A., Harrington, J., Echevarria, L., Davis, L. E., Goade, D., Harnar, J., Nofchissey, R. A., Sewell, C. M., Ettestad, P., & Haaland, K. Y. (2009). Persistent neuropsychological impairment associated with West Nile virus infection. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390902881918
546. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
547. Sahakian, B. J., & Savulich, G. (2019). Innovative methods for improving cognition, motivation and wellbeing in schizophrenia. World Psychiatry. https://doi.org/10.1002/wps.20649
548. Salamah, H. K. Z., Mortier, E., Wassenberg, R., & Strik, J. J. M. H. (2022). Lost in another language: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-021-03236-z
549. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
550. Santoso, L. F., Kim, D. Y., & Paydarfar, D. (2019). Sensory dysphagia: A case series and proposed classification of an under recognized swallowing disorder. Head & Neck. https://doi.org/10.1002/hed.25588
551. Sardelić, S., & Šikić, N. (2008). Neurogenic stuttering in children. Paediatria Croatica. https://doi.org/10.13112/pc.935
552. Sarnat, H. B. (1987). Disturbances of Late Neuronal Migrations in the Perinatal Period. Archives of Pediatrics and Adolescent Medicine. https://doi.org/10.1001/archpedi.1987.04460090046022
553. Sass, L. A., Borda, J. P., Madeira, L., Pienkos, E., & Nelson, B. (2018). Varieties of Self Disorder: A Bio-Pheno-Social Model of Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sby001
554. Sawarkar, A., Shambharkar, R., Shambharkar, M., Khandar, J., Sakharwade, P., & Kasturkar, P. (2021). Case Report on Acute Transient Psychotic Disorder. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2021/v33i45b32783
555. Sc, D., Mj, W., Hh, K.-L., Houten, V., & Eurelings, M. (2014). [Concentration problem or epilepsy? Sudden changes in behaviour in adolescents].. PubMed.
556. Scarpa, M., Harmatz, P., Meesen, B., & Giugliani, R. (2018). Outcomes of a Physician Survey on the Type, Progression, Assessment, and Treatment of Neurological Disease in Mucopolysaccharidoses. Journal of Inborn Errors of Metabolism and Screening. https://doi.org/10.1177/2326409818759370
557. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
558. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
559. Schildkrout, B. (2014). Disease #16: Frontotemporal Dementia. https://doi.org/10.1002/9781394260447.ch44
560. Schildkrout, B. (2014). Motor Behavior. https://doi.org/10.1002/9781394260447.ch22
561. Schildkrout, B. (2014). Speech and Language. https://doi.org/10.1002/9781394260447.ch15
562. Schlachetzki, J. C. M. (2011). Frontotemporal Lobar Degeneration. InTech eBooks. https://doi.org/10.5772/28174
563. Schlotawa, L., Adang, L., Castro, M. D., & Ahrens‐Nicklas, R. C. (2019). Multiple Sulfatase Deficiency.
564. Schwartzman, R. J. (2012). Systemic Complications of Complex Regional Pain Syndrome. Neuroscience &amp Medicine. https://doi.org/10.4236/nm.2012.33027
565. Scott, D. A., & Sherr, E. H. (2019). RERE-Related Disorders.
566. Seeman, P., & Seeman, M. V. (2011). Schizophrenia and the supersensitive synapse. Neuropsychiatry. https://doi.org/10.2217/npy.11.18
567. Seifert, B., Lukáš, K., Charvátová, E., Vojtíšková, J., Koudelka, T., Hep, A., Bureš, J., Jirásek, V., & Dítě, P. (2007). Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006.
568. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
569. Sever, J. (2016). Use of the aphasia test with slovenian-italian and italian-slovenian bilingual patients with broca aphasia.
570. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
571. Shany‐Ur, T., & Rankin, K. P. (2011). Personality and social cognition in neurodegenerative disease. Current Opinion in Neurology. https://doi.org/10.1097/wco.0b013e32834cd42a
572. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
573. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
574. SheikhBahaei, S., Farhan, M., & Maguire, G. A. (2022). Improvement of stuttering after administration of methylphenidate - a case report. Personalized Medicine in Psychiatry. https://doi.org/10.1016/j.pmip.2022.100092
575. Sheinfeld, H., Ga�l, M., Bunzel, M. E., & Vishne, T. (2007). The Etiology of Some Menstrual Disorders: A Gynecological and Psychiatric Issue. Health Care For Women International. https://doi.org/10.1080/07399330701563178
576. Shende, V., & Patel, F. R. (2014). AGMATINE AMELIORATES SOCIAL ISOLATION INDUCED OBSESSIVE-COMPULSIVE BEHAVIOR IN MICE.
577. Sher, L. (2015). Parental alienation: the impact on men’s mental health. International Journal of Adolescent Medicine and Health. https://doi.org/10.1515/ijamh-2015-0083
578. Shibasaki, H., & Hallett, M. (2016). Psychogenic Neurologic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190240974.003.0026
579. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Disorders of Increased Muscle Stiffness or Overactivity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0009
580. Shorvon, S. (1987). Intensive Neurodiagnostic Monitoring. (Advances in Neurology Vol 46).. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.9.1247-a
581. Shprecher, D., & Mehta, L. (2010). The syndrome of delayed post-hypoxic  leukoencephalopathy.. PubMed.
582. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
583. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
584. Sinard, J. H., & Hedreen, J. C. (1995). Neuronal loss from the subthalamic nuclei in a patient with progressive chorea. Movement Disorders. https://doi.org/10.1002/mds.870100313
585. Singer, H. S., & Augustine, F. (2019). The Pathophysiology of Tics; An Evolving Story. Current Drug Therapy. https://doi.org/10.2174/1574885514666191121143930
586. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
587. Skraban, C., Grand, K., & Deardorff, M. A. (2019). WDR26-Related Intellectual Disability.
588. Smith, M. (2005). Mental Retardation Associated with Dysmorphology, Growth Retardation, or Overgrowth. https://doi.org/10.1093/oso/9780195174328.003.0004
589. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
590. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
591. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
592. Spikman, J. M., Westerhof-Evers, H. J., & Cassel, A. (2021). Remediating impairments in social cognition. Routledge eBooks. https://doi.org/10.4324/9781003027034-11
593. Sreenivasan, S., Eth, S., Kirkish, P., & Garrick, T. (2003). A practical method for the evaluation of symptom exaggeration in minor head trauma among civil litigants.. PubMed.
594. Staniloiu, A., & Markowitsch, H. J. (2013). 1687 – Social cognition in patients with dissociative amnesia. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76675-6
595. Staniloiu, A., & Markowitsch, H. J. (2013). 1699 – Long lasting personality changes after the onset of dissociative amnesia. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76685-9
596. Staretz‐Chacham, O., Choi, J. H., Wakabayashi, K., Lopez, G., & Sidransky, E. (2010). Psychiatric and behavioral manifestations of lysosomal storage disorders. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.31097
597. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
598. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
599. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
600. Stone, J., Warlow, C., & Sharpe, M. (2011). Functional weakness: clues to mechanism from the nature of onset. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2011-300125
601. Stratakis, C. A., Gold, P. W., & Chrousos, G. P. (1995). Neuroendocrinology of Stress: Implications for Growth and Development. Hormone Research. https://doi.org/10.1159/000184269
602. Stroe, A. Z., Ciorabai, E. M., Pantu, C., Stuparu, A. F., Muja, L., Vranau, D., Axelerad, S. D., & Axelerad, A. D. (2023). Unveiling the Mind: A Comprehensive Review of Psychiatric Disorders in Parkinson’s Disease. Ars medica tomitana. https://doi.org/10.2478/arsm-2023-0007
603. Strupp, M., Straumann, D., & Helmchen, C. (2021). Nystagmus: Diagnosis, Topographic Anatomical Localization and Therapy. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/a-1525-0030
604. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
605. Suchowersky, O., Reich, S. G., Perlmutter, J. S., Zesiewicz, T., Gronseth, G., & Weiner, W. J. (2006). Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) [RETIRED]. Neurology. https://doi.org/10.1212/01.wnl.0000215437.80053.d0
606. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
607. Sumeyra, H. A. (2021). PSYCHO-PEDAGOGICAL CHARACTERISTICS OF YOUNG STUTTERING STUDENTS. Innovate Pedagogy. https://doi.org/10.32843/2663-6085/2021/40.21
608. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
609. Sunarti, S., & Helena, H. (2018). Gangguan Tidur pada Lanjut Usia. Journal of Islamic Medicine. https://doi.org/10.18860/jim.v2i1.5009
610. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
611. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
612. Surguladze, S., Keedwell, P., & Phillips, M. L. (2003). Neural systems underlying affective disorders. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.9.6.446
613. Swann, A. C. (2012). Impulsivity and Affective Regulation. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195389715.013.0084
614. Swillen, A., & McDonald‐McGinn, D. M. (2015). Developmental trajectories in 22q11.2 deletion syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31435
615. Szabó, L., & Szabó, M. (2003). [Two cases of frontotemporal dementia].. PubMed.
616. Tachampa, K. (2015). Exercise Intolerance: How Do We Know and Test?.
617. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
618. Tang, K., Antshel, K. M., Fremont, W., & Kates, W. R. (2015). Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome. Journal of Developmental & Behavioral Pediatrics. https://doi.org/10.1097/dbp.0000000000000210
619. Tantam, D. (1988). Lifelong Eccentricity and Social Isolation. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.153.6.783
620. Taylor, M. E., & Whitney, J. (2021). Impaired Cognition and Falls. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594455.009
621. Thavapalan, V., Liang, T., & Rakočević, G. (2015). Novel OPA1 Mutation in Syndromic Mitochondrial Dominant Optic Atrophy (DOA+): A Case Report (P7.074). Neurology. https://doi.org/10.1212/wnl.84.14_supplement.p7.074
622. Thomas, P. (2003). Treatment options for acute mania. European Psychiatry. https://doi.org/10.1016/s0924-9338(03)80011-1
623. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
624. Tian, C., Darmahkasih, A., Rybalsky, I., Shellenbarger, K., Horn, P. S., Lambert, J. T., & Wong, B. (2020). Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Muscle & Nerve. https://doi.org/10.1002/mus.26803
625. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
626. Tong, J., Hawi, Z., & Bellgrove, M. A. (2016). Attention Deficit Hyperactivity Disorder. Psychology Press eBooks. https://doi.org/10.4324/9781315692289-8
627. Toone, B. (2004). Attention deficit hyperactivity disorder in adulthood. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2002.002022
628. Trivedi, J. K. (2006). Cognitive deficits in psychiatric disorders: Current status. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.31613
629. Trivedi, K., Kataria, L., & Patel, D. (2020). A COMPARATIVE STUDY EVALUATING THE DEPRESSIVE SYMPTOMS AND FUNCTIONAL OUTCOME IN PATIENTS TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS V/S SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS AS ANTIDEPRESSANT AGENTS IN MAJOR DEPRESSIVE DISORDER.
630. Trosch, R., Comella, C. L., Caroff, S. N., Ondo, W. G., Shillington, A. C., LaChappelle, B., Hauser, R. A., Correll, C. U., & Friedman, J. H. (2023). Reliability of the Clinician’s Tardive Inventory (CTI). CNS Spectrums. https://doi.org/10.1017/s1092852923001347
631. Truzzi, A., & Ripoli, C. (2019). Sympathetic Activation in Response to Infant Cry: Distress or Promptness to Action?. Parenting. https://doi.org/10.1080/15295192.2019.1555418
632. Tsekhmister, Y., & Lunov, V. (2019). Psychological Peculiarities of Future Doctors Neurotization under the Trilingualism Condition. International Journal of Recent Technology and Engineering (IJRTE). https://doi.org/10.35940/ijrte.d1009.1184s19
633. Tuchman, R., Moshé, S. L., & Rapin, I. (2005). Trastornos del neurodesarrollo y epilepsia. Revista de Neurología. https://doi.org/10.33588/rn.40s01.2004649
634. Turk, J., Graham, P. L., & Verhulst, F. C. (2007). Prevention and treatment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199216697.003.0009
635. Ullman, M. T. (2013). The role of declarative and procedural memory in disorders of language. Linguistic Variation. https://doi.org/10.1075/lv.13.2.01ull
636. Urazán, D. T., Barragán, A. G., Hernández, K. D. C. P., & Gamboa, D. J. (2023). Afasia primaria progresiva variante no fluente/agramática. Acta neurológica colombiana. https://doi.org/10.22379/anc.v39i3.853
637. Valeriano, J., McConnell, H., & Brillman, J. C. (1995). Prenuptial seizures: a report of five cases. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.7.1.72
638. Vargha‐Khadem, F. (2001). Generalized Versus Selective Cognitive Impairments Resulting from Brain Damage Sustained in Childhood. Epilepsia. https://doi.org/10.1046/j.1528-1157.2001.00513.x
639. Varı̀, M. R., Pichini, S., Giorgetti, R., & Busardò, F. P. (2018). New psychoactive substances—Synthetic stimulants. Wiley Interdisciplinary Reviews Forensic Science. https://doi.org/10.1002/wfs2.1197
640. Vasquez-Baiocchi, M. A. J., & Burneo, J. G. (2021). Epilepsias mioclónicas progresivas. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v83i4.3891
641. Velleman, S. L., & Mervis, C. Β. (2011). Children With 7q11.23 Duplication Syndrome: Speech, Language, Cognitive, and Behavioral Characteristics and Their Implications for Intervention. Perspectives on Language Learning and Education. https://doi.org/10.1044/lle18.3.108
642. Vellucci, L., Ciccarelli, M., Buonaguro, E. F., Fornaro, M., D’Urso, G., Simone, G. D., Iasevoli, F., Barone, A., & Bartolomeis, A. D. (2023). The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia. Biomolecules. https://doi.org/10.3390/biom13081220
643. Vergano, S. A. S., Sluijs, P. J. V. D., & Santen, G. W. (2019). ARID1B-Related Disorder.
644. Vernino, S., Geschwind, M. D., & Boeve, B. F. (2007). Autoimmune Encephalopathies. The Neurologist. https://doi.org/10.1097/01.nrl.0000259483.70041.55
645. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
646. Villacis, K. M. B., Menéndez, N. M. R., & Cedeño, E. Z. (2019). Diferencia entre el trastorno por déficit de atención/ hiperactividad (TDAH) y los trastornos del lenguaje. Atlante Cuadernos de Educación y Desarrollo.
647. Virmani, A., Ali, S. F., & Binienda, Z. (2010). Neuroprotective strategies in drug abuse‐evoked encephalopathy. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2009.05171.x
648. Volpe, B. T. (1997). Delayed Neuronal Degeneration Results from Endogenous Glutamate Excess. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48390.x
649. Vonk, J. M. J., Borghesani, V., Battistella, G., Younes, K., Deleon, J., Welch, A. E., Hubbard, H. I., Miller, Z., Miller, B. L., & Gorno‐Tempini, M. L. (2019). Verbal semantics and the left dorsolateral anterior temporal lobe: a longitudinal case of bilateral temporal degeneration. Aphasiology. https://doi.org/10.1080/02687038.2019.1659935
650. Vuković, M., & Todorović, J. (2021). Eating and swallowing disorders in children with cerebral palsy. Medicinski pregled. https://doi.org/10.2298/mpns2106200v
651. Walker, A. E. (2023). Custody and Restraint Deaths. CRC Press eBooks. https://doi.org/10.1201/9781003138754-30
652. Wallace, S. J. (2015). Epilepsy in children. Chapman & Hall Medical eBooks.
653. Walther, S. (2018). Motorische Auffälligkeiten bei Schizophrenie: Effekte auf Kommunikation und mögliche Therapieoptionen.
654. Wang, R., & Bi, H. (2021). Auditory temporal processing deficits in developmental dyslexia. Advances in Psychological Science. https://doi.org/10.3724/sp.j.1042.2021.01231
655. Waters, K. A. (2010). Serotonin in the sudden infant death syndrome. Drug News & Perspectives. https://doi.org/10.1358/dnp.2010.23.9.1453626
656. Weinberg, M. A., Segelnick, S. L., Insler, J. S., & Kramer, S. (2015). Diseases of the neurological system. https://doi.org/10.1002/9781118991473.ch8
657. White, L. R., Hemmy, L. S., Flanagan, M. E., Kawas, C. H., Corrada, M. M., Edland, S. D., & Montine, T. J. (2018). P1‐111: RESISTANCE, RESERVE, AND RESILIENCE: SYSTEMS THAT DEFEND AGAINST AGE‐RELATED COGNITIVE DECLINE—OBSERVATIONS FROM THE HONOLULU‐ASIA AGING STUDY (HAAS). Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2018.06.114
658. Wiebe, D. J., Comstock, R. D., & Nance, M. L. (2011). Concussion research: a public health priority. Injury Prevention. https://doi.org/10.1136/ip.2010.031211
659. Wierenga, C. E., & Bondi, M. W. (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations.
660. Winter, A., & Buhlmann, U. (2013). Spieglein, Spieglein an der Wand … Klinische Charakteristika der körperdysmorphen Störung. Zeitschrift für Psychiatrie Psychologie und Psychotherapie. https://doi.org/10.1024/1661-4747/a000155
661. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
662. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
663. Yazıcı, K. U., & Yazıcı, A. (2010). Dürtüselliğin Nöroanatomik ve Nörokimyasal Temelleri. https://doi.org/10.18863/pgy.83834
664. Yoshino, M. (2011). [The logopenic variant of primary progressive aphasia].. PubMed.
665. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
666. Youssef, P. E., Mack, K. J., & Flemming, K. D. (2015). Classification and Approach to Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0024
667. Yui, K. (2015). EDITORIAL (Thematic Issue: New Targets of Medical Treatment in Psychiatric Disorders). Current Neuropharmacology. https://doi.org/10.2174/1570159x1306151126144423
668. Zamorski, M. A., & Ward, R. (2000). Social Anxiety Disorder: Common, Disabling, and Treatable. The Journal of the American Board of Family Medicine. https://doi.org/10.3122/15572625-13-4-251
669. Zengaffinen, F. S., Stahnke, A., Furger, S., Dierks, T., Federspiel, A., Hatzinger, M., König, T., Nick, B., Rapp, C., Stegmayer, K., Strik, W., Walther, S., Wiest, R., & Papmeyer, M. (2017). Jumping to Associations during Psychosis.
670. Zhang, Y. (2021). Investigation of the Effects of SIRT1 and SIRT2 Modulators in Neuroinflammatory Models of Depression. https://doi.org/10.25904/1912/4137
671. Zhao, M., & Hao, W. (2019). Challenges of gaming disorder: suggestions from a public health perspective. General Psychiatry. https://doi.org/10.1136/gpsych-2019-100086
672. Zinner, S. H., & Mink, J. W. (2010). Movement Disorders I: Tics and Stereotypies. Pediatrics in Review. https://doi.org/10.1542/pir.31-6-223
673. Zorumski, C. F., & Rubin, E. H. (2009). What Illnesses Do Psychiatrists Treat?. https://doi.org/10.1093/oso/9780195386400.003.0002